Document:

Exhibit 10.2

 

Execution version

 

REGISTRATION RIGHTS
AGREEMENT

 

This REGISTRATION RIGHTS
AGREEMENT (this “Agreement”), dated as of June 18, 2021, is by and between Seven Knots, LLC, a Montana limited
liability company (the “Investor”), and Ashford Hospitality Trust, Inc., a Maryland corporation (the “Company”).

 

RECITALS

 

A.       The
Company, Ashford Hospitality Limited Partnership, a Delaware limited partnership, and the Investor have entered into that certain Common
Stock Purchase Agreement, dated as of the date hereof (the “Purchase Agreement”), pursuant to which the Company
may issue, from time to time, to the Investor up to 40,093,080 shares of the Company’s common stock, par value $0.01 per share (“Common
Stock”), subject to the Aggregate Limit, as provided for therein.

 

B.       Pursuant
to the terms of, and in consideration for the Investor entering into, the Purchase Agreement, and to induce the Investor to execute and
deliver the Purchase Agreement, the Company has agreed to provide the Investor with certain registration rights with respect to the Registrable
Securities (as defined herein) as set forth herein.

 

AGREEMENT

 

NOW, THEREFORE, in
consideration of the representations, warranties, covenants and agreements contained herein and in the Purchase Agreement, and for other
good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, intending to be legally bound hereby, the
Company and the Investor hereby agree as follows:

 

		1.	Definitions.

 

Capitalized terms used herein
and not otherwise defined herein shall have the respective meanings set forth in the Purchase Agreement. As used in this Agreement, the
following terms shall have the following meanings:

 

(a)              
“Agreement” shall have the meaning assigned to such term in the preamble of this Agreement

 

(b)              
“Allowable Grace Period” shall have the meaning assigned to such term in Section 3(p).

 

(c)              
“Blue Sky Filing” shall have the meaning assigned to such term in Section 6(a).

 

(d)              
“Business Day” means any day other than Saturday, Sunday or any other day on which commercial banks in
New York, New York are authorized or required by law to remain closed.

 

(e)              
“Claims” shall have the meaning assigned to such term in Section 6(a).

 

    

     

    

 

(f)               
 “Commission” means the U.S. Securities and Exchange Commission or any successor entity.

 

(g)              
“Common Stock” shall have the meaning assigned to such term in the recitals to this Agreement.

 

(h)              
“Company” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(i)                
“Effective Date” means the date that the applicable Registration Statement has been declared effective
by the Commission.

 

(j)                
“Effectiveness Deadline” means (i) with respect to the Initial Registration Statement required to be
filed to pursuant to Section 2(a), the earlier of (A) the 60th calendar day after the date of this Agreement, if such Registration
Statement is subject to review by the Commission, and (B) the 30th calendar day after the date of this Agreement, if the Company
is notified (orally or in writing, whichever is earlier) by the Commission that such Registration Statement will not be reviewed and (ii)
with respect to any New Registration Statements that may be required to be filed by the Company pursuant to this Agreement, the earlier
of (A) the 60th calendar day following the date on which the Company was required to file such additional Registration Statement,
if such Registration Statement is subject to review by the Commission, and (B) the 30th calendar day following the date on
which the Company was required to file such New Registration Statement, if the Company is notified (orally or in writing, whichever is
earlier) by the Commission that such Registration Statement will not be reviewed.

 

(k)              
“Filing Deadline” means (i) with respect to the Initial Registration Statement required to be filed to
pursuant to Section 2(a), the 10th Business Day after the date of this Agreement and (ii) with respect to any New Registration
Statements that may be required to be filed by the Company pursuant to this Agreement, the 15th Business Day following the
sale of substantially all of the Registrable Securities included in the Initial Registration Statement or the most recent prior New Registration
Statement, as applicable, or such other date as permitted by the Commission.

 

(l)                
“Indemnified Damages” shall have the meaning assigned to such term in Section 6(a).

 

(m)            
“Initial Registration Statement” shall have the meaning assigned to such term in Section 2(a).

 

(n)              
“Investor” shall have the meaning assigned to such term in the preamble of this Agreement.

 

(o)              
“Investor Party” and “Investor Parties” shall have the meaning assigned to such terms in
Section 6(a).

 

(p)              
“Legal Counsel” shall have the meaning assigned to such term in Section 2(b).

 

    2 

     

    

 

(q)              
 “New Registration Statement” shall have the meaning assigned to such term in Section 2(c).

 

(r)               
“Person” means any person or entity, whether a natural person, trustee, corporation, partnership, limited
partnership, limited liability company, trust, unincorporated organization, business association, firm, joint venture, governmental agency
or authority.

 

(s)              
“Prospectus” means the prospectus in the form included in the Registration Statement, as supplemented
from time to time by any Prospectus Supplement, including the documents incorporated by reference therein.

 

(t)                
“Prospectus Supplement” means any prospectus supplement to the Prospectus filed with the Commission from
time to time pursuant to Rule 424(b) under the Securities Act, including the documents incorporated by reference therein.

 

(u)              
“Purchase Agreement” shall have the meaning assigned to such term in the recitals to this Agreement.

 

(v)              
“register,” “registered,” and “registration” refer
to a registration effected by preparing and filing one or more Registration Statements in compliance with the Securities Act and pursuant
to Rule 415 and the declaration of effectiveness of such Registration Statement(s) by the Commission.

 

(w)            
“Registrable Securities” means all of (i) the Shares, (ii) any capital stock of the Company issued or
issuable with respect to such Shares, including, without limitation, (1) as a result of any stock split, stock dividend, recapitalization,
exchange or similar event or otherwise and (2) shares of capital stock of the Company into which the shares of Common Stock are converted
or exchanged and shares of capital stock of a successor entity into which the shares of Common Stock are converted or exchanged, in each
case until such time as such securities cease to be Registrable Securities pursuant to Section 2(f).

 

(x)              
“Registration Statement” means a registration statement or registration statements of the Company filed
under the Securities Act covering the resale by the Investor of Registrable Securities, as such registration statement or registration
statements may be amended and supplemented from time to time, including all documents filed as part thereof or incorporated by reference
therein.

 

(y)              
“Registration Period” shall have the meaning assigned to such term in Section 3(a).

 

(z)              
“Rule 144” means Rule 144 promulgated by the Commission under the Securities Act, as such rule may be
amended from time to time, or any other similar or successor rule or regulation of the Commission that may at any time permit the Investor
to sell securities of the Company to the public without registration.

 

(aa)           
“Rule 415” means Rule 415 promulgated by the Commission under the Securities Act, as such rule may be
amended from time to time, or any other similar or successor rule or regulation of the Commission providing for offering securities on
a delayed or continuous basis.

 

    3 

     

    

 

(bb)          
 “Staff” shall have the meaning assigned to such term in Section 2(e).

 

(cc)           
“Violations” shall have the meaning assigned to such term in Section 6(a).

 

		2.	Registration.

 

(a)       Mandatory
Registration. The Company shall prepare and, as soon as practicable, but in no event later than the Filing Deadline, file with the
Commission an initial Registration Statement on Form S-11 (or any successor form) covering the resale by the Investor of the maximum number
of Registrable Securities as shall be permitted to be included thereon in accordance with applicable Commission rules, regulations and
interpretations so as to permit the resale of such Registrable Securities by the Investor under Rule 415 under the Securities Act at then
prevailing market prices (and not fixed prices) (the “Initial Registration Statement”). Such initial Registration
Statement shall contain the “Selling Stockholder” and “Plan of Distribution” sections in substantially the form
attached hereto as Exhibit B. The Company shall use its commercially reasonable efforts to have the Initial Registration Statement
declared effective by the Commission as soon as reasonably practicable, but in no event later than the applicable Effectiveness Deadline.

 

(b)       Legal
Counsel. Subject to Section 5 hereof, the Investor shall have the right to select one legal counsel to review and oversee, solely
on its behalf, any registration pursuant to this Section 2 (“Legal Counsel”), which shall be Dorsey & Whitney
LLP, or such other counsel as thereafter designated by the Investor. Except as provided under Section 10.1(i) of the Purchase Agreement,
the Company shall have no obligation to reimburse the Investor for any and all legal fees and expenses of the Legal Counsel incurred in
connection with the transactions contemplated hereby.

 

(c)       Sufficient
Number of Shares Registered. If at any time all Registrable Securities are not covered by the Initial Registration Statement filed
pursuant to Section 2(a) as a result of Section 2(e) or otherwise, the Company shall use its commercially reasonable efforts to file with
the Commission one or more additional Registration Statements so as to cover all of the Registrable Securities not covered by such initial
Registration Statement, in each case, as soon as practicable (taking into account any position of the staff of the Commission (“Staff”)
with respect to the date on which the Staff will permit such additional Registration Statement(s) to be filed with the Commission and
the rules and regulations of the Commission) (each such additional Registration Statement, a “New Registration Statement”),
but in no event later than the applicable Filing Deadline for such New Registration Statement(s). The Company shall use its commercially
reasonable efforts to cause each such New Registration Statement to become effective as soon as practicable following the filing thereof
with the Commission, but in no event later than the applicable Effectiveness Deadline for such New Registration Statement.

 

(d)       No
Inclusion of Other Securities. In no event shall the Company include any securities other than Registrable Securities on any Registration
Statement pursuant to Section 2(a) or Section 2(c) without consulting the Investor and Legal Counsel prior to filing such Registration
Statement with the Commission.

 

    4 

     

    

 

(e)       Offering.
If the Staff or the Commission seeks to characterize any offering pursuant to a Registration Statement filed pursuant to this Agreement
as constituting an offering of securities that does not permit such Registration Statement to become effective and be used for resales
by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed prices), or if after the
filing of any Registration Statement pursuant to Section 2(a) or Section 2(c), the Company is otherwise required by the Staff or the Commission
to reduce the number of Registrable Securities included in such Registration Statement, then the Company shall reduce the number of Registrable
Securities to be included in such Registration Statement (after consultation with the Investor and Legal Counsel as to the specific Registrable
Securities to be removed therefrom) until such time as the Staff and the Commission shall so permit such Registration Statement to become
effective and be used as aforesaid. Notwithstanding anything in this Agreement to the contrary, if after giving effect to the actions
referred to in the immediately preceding sentence, the Staff or the Commission does not permit such Registration Statement to become effective
and be used for resales by the Investor on a delayed or continuous basis under Rule 415 at then-prevailing market prices (and not fixed
prices), the Company shall not request acceleration of the Effective Date of such Registration Statement, the Company shall promptly (but
in no event later than 48 hours) request the withdrawal of such Registration Statement pursuant to Rule 477 under the Securities Act,
and the Effectiveness Deadline shall automatically be deemed to have elapsed with respect to such Registration Statement at such time
as the Staff or the Commission has made a final and non-appealable determination that the Commission will not permit such Registration
Statement to be so utilized (unless prior to such time the Company has received assurances from the Staff or the Commission that a New
Registration Statement filed by the Company with the Commission promptly thereafter may be so utilized). In the event of any reduction
in Registrable Securities pursuant to this paragraph, the Company shall use its commercially reasonable efforts to file one or more New
Registration Statements with the Commission in accordance with Section 2(c) until such time as all Registrable Securities have been included
in Registration Statements that have been declared effective and the Prospectuses contained therein are available for use by the Investor.

 

(f)       Any
Registrable Security shall cease to be a “Registrable Security” at the earliest of the following: (i) when a Registration
Statement covering such Registrable Security becomes or has been declared effective by the Commission and such Registrable Security has
been sold or disposed of pursuant to such effective Registration Statement; (ii) when such Registrable Security is held by the Company
or one of its Subsidiaries; and (iii) the date that is the later of (A) the first (1st) anniversary of the date of termination
of the Purchase Agreement in accordance with Article VIII of the Purchase Agreement and (B) the first (1st) anniversary of
the date of the last issuance or sale by the Company of any Registrable Securities to the Investor pursuant to the Purchase Agreement.

 

    5 

     

    

 

		3.	Related Obligations.

 

The Company shall use its
commercially reasonable efforts to effect the registration of the Registrable Securities in accordance with the intended method of disposition
thereof, and, pursuant thereto, the Company shall have the following obligations:

 

(a)       The
Company shall promptly prepare and file with the Commission the Initial Registration Statement pursuant to Section 2(a) hereof and
one or more New Registration Statements pursuant to Section 2(c) hereof with respect to the Registrable Securities, but in no event
later than the applicable Filing Deadline therefor, and the Company use its commercially reasonable efforts to cause each such
Registration Statement to become effective as soon as practicable after such filing, but in no event later than the applicable
Effectiveness Deadline therefor. Subject to Allowable Grace Periods, the Company shall keep each Registration Statement effective
(and the Prospectus contained therein available for use) pursuant to Rule 415 for resales by the Investor on a continuous basis at
then-prevailing market prices (and not fixed prices) at all times until the earlier of (i) the date on which the Investor shall have
sold all of the Registrable Securities covered by such Registration Statement and (ii) the date of termination of the Purchase
Agreement if as of such termination date the Investor holds no Registrable Securities (or, if applicable, the date on which such
securities cease to be Registrable Securities after the date of termination of the Purchase Agreement) (the
 “Registration Period”). Notwithstanding anything to the contrary contained in this Agreement (but subject
to the provisions of Section 3(q) hereof), the Company shall ensure that, when filed and at all times while effective, each
Registration Statement (including, without limitation, all amendments and supplements thereto) and the Prospectus (including,
without limitation, all amendments and supplements thereto) used in connection with such Registration Statement shall not contain
any untrue statement of a material fact or omit to state a material fact required to be stated therein, or necessary to make the
statements therein (in the case of Prospectuses, in the light of the circumstances in which they were made) not misleading. The
Company shall submit to the Commission, as soon as reasonably practicable after the date that the Company learns that no review of a
particular Registration Statement will be made by the Staff or that the Staff has no further comments on a particular Registration
Statement (as the case may be), a request for acceleration of effectiveness of such Registration Statement to a time and date as
soon as reasonably practicable in accordance with Rule 461 under the Securities Act.

 

    6 

     

    

 

(b)       Subject
to Section 3(q) of this Agreement, the Company shall use its commercially reasonable efforts to prepare and file with the Commission
such amendments (including, without limitation, post-effective amendments) and supplements to each Registration Statement and the
Prospectus used in connection with each such Registration Statement, which Prospectus is to be filed pursuant to Rule 424
promulgated under the Securities Act, as may be necessary to keep each such Registration Statement effective (and the Prospectus
contained therein current and available for use) at all times during the Registration Period for such Registration Statement, and,
during such period, comply with the provisions of the Securities Act with respect to the disposition of all Registrable Securities
of the Company required to be covered by such Registration Statement until such time as all of such Registrable Securities shall
have been disposed of in accordance with the intended methods of disposition by the Investor. Without limiting the generality of the
foregoing, the Company covenants and agrees that (i) at or before 8:30 a.m. (New York City time) on the Trading Day immediately
following the Effective Date of the Initial Registration Statement and any New Registration Statement (or any post-effective
amendment thereto), the Company shall file with the Commission in accordance with Rule 424(b) under the Securities Act the final
Prospectus to be used in connection with sales pursuant to such Registration Statement (or post-effective amendment thereto), and
(ii) if the transactions contemplated by any Fixed Purchase and related VWAP Purchase and Additional VWAP Purchase (as applicable)
are material to the Company (individually or collectively with all other prior Fixed Purchases, VWAP Purchases and Additional VWAP
Purchases, the consummation of which have not previously been reported in any Prospectus Supplement filed with the Commission under
Rule 424(b) under the Securities Act or in any report, statement or other document filed by the Company with the Commission under
the Exchange Act), or if otherwise required under the Securities Act (or the interpretations of the Commission thereof), in each
case as reasonably determined by the Company and the Investor, then, within the time period prescribed under Rule 424(b) under the
Securities Act, the Company shall file with the Commission a Prospectus Supplement pursuant to Rule 424(b) under the Securities Act
with respect to the applicable Fixed Purchase(s), VWAP Purchase(s) and Additional VWAP Purchase(s) (as applicable), disclosing the
total number of Shares that are to be (and, if applicable, have been) issued and sold to the Investor pursuant to such purchase(s),
the total purchase price for the Shares subject to such purchase(s), the applicable purchases price(s) for such Shares and the net
proceeds that are to be (and, if applicable, have been) received by the Company from the sale of such Shares. To the extent not
previously disclosed in the Prospectus or a Prospectus Supplement, the Company shall disclose in its Quarterly Reports on Form 10-Q
and in its Annual Reports on Form 10-K the information described in the immediately preceding sentence relating to all Fixed
Purchase(s), VWAP Purchase(s) and Additional VWAP Purchases consummated during the relevant fiscal quarter and shall file such
Quarterly Reports and Annual Reports with the Commission within the applicable time period prescribed for such report under the
Exchange Act. In the case of amendments and supplements to any Registration Statement on Form S-11 or Prospectus related thereto
which are required to be filed pursuant to this Agreement (including, without limitation, pursuant to this Section 3(b)) by reason
of the Company filing a report on Form 8-K, Form 10-Q or Form 10-K or any analogous report under the Exchange Act, the Company shall
have incorporated such report by reference into such Registration Statement and Prospectus, if applicable, or shall file such
amendments or supplements to the Registration Statement or Prospectus with the Commission on the same day on which the Exchange Act
report is filed which created the requirement for the Company to amend or supplement such Registration Statement or Prospectus, for
the purpose of including or incorporating such report into such Registration Statement and Prospectus. The Company consents to the
use of the Prospectus (including, without limitation, any supplement thereto) included in each Registration Statement in accordance
with the provisions of the Securities Act and with the securities or “Blue Sky” laws of the jurisdictions in which the
Registrable Securities may be sold by the Investor, in connection with the resale of the Registrable Securities and for such period
of time thereafter as such Prospectus (including, without limitation, any supplement thereto) (or in lieu thereof, the notice
referred to in Rule 173(a) under the Securities Act) is required by the Securities Act to be delivered in connection with resales of
Registrable Securities.

 

(c)       The
Company shall (A) permit Legal Counsel an opportunity to review and comment upon (i) each Registration Statement at least two (2)
Business Days prior to its filing with the Commission and (ii) all amendments and supplements to each Registration Statement
(including, without limitation, the Prospectus contained therein) (except for Annual Reports on Form 10-K, Quarterly Reports on Form
10-Q, Current Reports on Form 8-K, and any similar or successor reports or Prospectus Supplements the contents of which is limited
to that set forth in such reports) within a reasonable number of days prior to their filing with the Commission, and (B) shall
reasonably consider any comments of the Investor and Legal Counsel on any such Registration Statement or amendment or supplement
thereto or to any Prospectus contained therein. The Company shall promptly furnish to Legal Counsel, without charge, (i) electronic
copies of any correspondence from the Commission or the Staff to the Company or its representatives relating to each Registration
Statement (which correspondence shall be redacted to exclude any material, non-public information regarding the Company or any of
its Subsidiaries), (ii) after the same is prepared and filed with the Commission, one (1) electronic copy of each Registration
Statement and any amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all
documents incorporated therein by reference, if requested by the Investor, and all exhibits and (iii) upon the effectiveness of
each Registration Statement, one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments
and supplements thereto; provided, however, the Company shall not be required to furnish any document (other than the Prospectus,
which may be provided in .PDF format) to Legal Counsel to the extent such document is available on EDGAR).

 

    7 

     

    

 

(d)       Without
limiting any obligation of the Company under the Purchase Agreement, the Company shall promptly furnish to the Investor, without charge,
(i) after the same is prepared and filed with the Commission, at least one (1) electronic copy of each Registration Statement and any
amendment(s) and supplement(s) thereto, including, without limitation, financial statements and schedules, all documents incorporated
therein by reference, if requested by the Investor, all exhibits thereto, (ii) upon the effectiveness of each Registration Statement,
one (1) electronic copy of the Prospectus included in such Registration Statement and all amendments and supplements thereto (or such
other number of copies as the Investor may reasonably request from time to time) and (iii) such other documents, including, without limitation,
copies of any final Prospectus and any Prospectus Supplement thereto, as the Investor may reasonably request from time to time in order
to facilitate the disposition of the Registrable Securities owned by the Investor; provided, however, the Company shall not be required
to furnish any document (other than the Prospectus, which may be provided in .PDF format) to the Investor to the extent such document
is available on EDGAR).

 

(e)       The
Company shall take such action as is reasonably necessary to (i) register and qualify, unless an exemption from registration and qualification
applies, the resale by the Investor of the Registrable Securities covered by a Registration Statement under such other securities or “Blue
Sky” laws of all applicable jurisdictions in the United States, (ii) prepare and file in those jurisdictions, such amendments (including,
without limitation, post-effective amendments) and supplements to such registrations and qualifications as may be necessary to maintain
the effectiveness thereof during the Registration Period, (iii) take such other actions as may be reasonably necessary to maintain such
registrations and qualifications in effect at all times during the Registration Period, and (iv) take all other actions reasonably necessary
or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided, however, the Company shall
not be required in connection therewith or as a condition thereto to (x) qualify to do business in any jurisdiction where it would not
otherwise be required to qualify but for this Section 3(e), (y) subject itself to general taxation in any such jurisdiction, or (z) file
a general consent to service of process in any such jurisdiction. The Company shall promptly notify Legal Counsel and the Investor of
the receipt by the Company of any notification with respect to the suspension of the registration or qualification of any of the Registrable
Securities for sale under the securities or “Blue Sky” laws of any jurisdiction in the United States or its receipt of actual
notice of the initiation or threatening of any proceeding for such purpose.

 

    8 

     

    

 

(f)       The
Company shall notify Legal Counsel and the Investor in writing of the happening of any event, as promptly as reasonably practicable
after becoming aware of such event, as a result of which the Prospectus included in a Registration Statement, as then in effect,
includes an untrue statement of a material fact or omission to state a material fact required to be stated therein or necessary to
make the statements therein, in the light of the circumstances under which they were made, not misleading (provided that in no event
shall such notice contain any material, non-public information regarding the Company or any of its Subsidiaries), and, subject to
Section 3(q), promptly prepare a supplement or amendment to such Registration Statement and such Prospectus contained therein to
correct such untrue statement or omission and deliver one (1) electronic copy of such supplement or amendment to Legal Counsel and
the Investor (or such other number of copies as Legal Counsel or the Investor may reasonably request). The Company shall also
promptly notify Legal Counsel and the Investor in writing (i) when a Prospectus or any Prospectus Supplement or post-effective
amendment has been filed, when a Registration Statement or any post-effective amendment has become effective (notification of such
effectiveness shall be delivered to Legal Counsel and the Investor by facsimile or e-mail on the same day of such effectiveness and
by overnight mail), and when the Company receives written notice from the Commission that a Registration Statement or any
post-effective amendment will be reviewed by the Commission, (ii) of any request by the Commission for amendments or supplements to
a Registration Statement or related Prospectus or related information, (iii) of the Company’s reasonable determination that a
post-effective amendment to a Registration Statement would be appropriate and (iv) of the receipt of any request by the Commission
or any other federal or state governmental authority for any additional information relating to the Registration Statement or any
amendment or supplement thereto or any related Prospectus. The Company shall respond as promptly as reasonably practicable to any
comments received from the Commission with respect to a Registration Statement or any amendment thereto. Nothing in this Section
3(f) shall limit any obligation of the Company under the Purchase Agreement.

 

(g)       The
Company shall (i) use its commercially reasonable efforts to prevent the issuance of any stop order or other suspension of effectiveness
of a Registration Statement or the use of any Prospectus contained therein, or the suspension of the qualification, or the loss of an
exemption from qualification, of any of the Registrable Securities for sale in any jurisdiction and, if such an order or suspension is
issued, to obtain the withdrawal of such order or suspension at the earliest possible time and (ii) notify Legal Counsel and the Investor
of the issuance of such order and the resolution thereof or its receipt of actual notice of the initiation or threat of any proceeding.

 

(h)       The
Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company unless (i)
disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information is
necessary to avoid or correct a misstatement or omission in any Registration Statement or is otherwise required to be disclosed in such
Registration Statement pursuant to the Securities Act, (iii) the release of such information is ordered pursuant to a subpoena or other
final, non-appealable order from a court or governmental body of competent jurisdiction, or (iv) such information has been made generally
available to the public other than by disclosure in violation of this Agreement or any other Transaction Document. The Company agrees
that it shall, upon learning that disclosure of such information concerning the Investor is sought in or by a court or governmental body
of competent jurisdiction or through other means, give prompt written notice to the Investor and allow the Investor, at the Investor’s
expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective order for, such information.

 

    9 

     

    

 

(i)       Without
limiting any obligation of the Company under the Purchase Agreement, the Company shall use its commercially reasonable efforts either
to (i) cause all of the Registrable Securities covered by each Registration Statement to be listed on the Trading Market, (ii) secure
designation and quotation of all of the Registrable Securities covered by each Registration Statement on another Eligible Market, or (iii)
if, despite the Company’s commercially reasonable efforts to satisfy the preceding clauses (i) or (ii) the Company is unsuccessful
in satisfying the preceding clauses (i) or (ii), without limiting the generality of the foregoing, to use its commercially reasonable
efforts to arrange for at least two market makers to register with the Financial Industry Regulatory Authority (“FINRA”)
as such with respect to such Registrable Securities. In addition, the Company shall reasonably cooperate with the Investor and any Broker-Dealer
through which the Investor proposes to sell its Registrable Securities in effecting a filing with FINRA pursuant to FINRA Rule 5110 as
requested by the Investor. The Company shall pay all fees and expenses in connection with satisfying its obligation under this Section
3(i).

 

(j)       The
Company shall cooperate with the Investor and, to the extent applicable, facilitate the timely preparation and delivery of Registrable
Securities, as DWAC Shares, to be offered pursuant to a Registration Statement and enable such DWAC Shares to be in such denominations
or amounts (as the case may be) as the Investor may reasonably request from time to time and registered in such names as the Investor
may request. Investor hereby agrees that it shall cooperate with the Company, its counsel and Transfer Agent in connection with any issuances
of DWAC Shares, and hereby represents, warrants and covenants to the Company that that it will resell such DWAC Shares only pursuant to
the Registration Statement in which such DWAC Shares are included, in a manner described under the caption “Plan of Distribution”
in such Registration Statement, and in a manner in compliance with all applicable U.S. federal and state securities laws, rules and regulations,
including, without limitation, any applicable prospectus delivery requirements of the Securities Act. DWAC Shares shall be free from all
restrictive legends may be transmitted by the transfer agent to the Investor by crediting an account at DTC as directed in writing by
the Investor.

 

(k)       Upon
the written request of the Investor, the Company shall as soon as reasonably practicable after receipt of notice from the Investor and
subject to Section 3(p) hereof, (i) incorporate in a Prospectus Supplement or post-effective amendment such information as the Investor
reasonably requests to be included therein relating to the sale and distribution of Registrable Securities, including, without limitation,
information with respect to the number of Registrable Securities being offered or sold, the purchase price being paid therefor and any
other terms of the offering of the Registrable Securities to be sold in such offering; (ii) make all required filings of such Prospectus
Supplement or post-effective amendment after being notified of the matters to be incorporated in such Prospectus Supplement or post-effective
amendment; and (iii) supplement or make amendments to any Registration Statement or Prospectus contained therein if reasonably requested
by the Investor.

 

(l)       The
Company shall use its commercially reasonable efforts to cause the Registrable Securities covered by a Registration Statement to be registered
with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of such Registrable
Securities.

 

    10 

     

    

 

(m)       The
Company shall make generally available to its security holders (which may be satisfied by making such information available on EDGAR)
as soon as practical, but not later than ninety (90) days after the close of the period covered thereby, an earnings statement (in form
complying with, and in the manner provided by, the provisions of Rule 158 under the Securities Act) covering a twelve-month period beginning
not later than the first day of the Company’s fiscal quarter next following the applicable Effective Date of each Registration Statement.

 

(n)       The
Company shall otherwise use its commercially reasonable efforts to comply with all applicable rules and regulations of the Commission
in connection with any registration hereunder.

 

(o)       Within
one (1) Business Day after each Registration Statement which covers Registrable Securities is declared effective by the Commission, the
Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor) confirmation that such Registration Statement has been declared effective by the Commission in the form
attached hereto as Exhibit A.

 

(p)       Notwithstanding
anything to the contrary contained herein (but subject to the last sentence of this Section 3(p)), at any time after the Effective
Date of a particular Registration Statement, the Company may, upon written notice to Investor, suspend Investor’s use of any
prospectus that is a part of any Registration Statement (in which event the Investor shall discontinue sales of the Registrable
Securities pursuant to such Registration Statement contemplated by this Agreement, but shall settle any previously made sales of
Registrable Securities) if the Company (x) is pursuing an acquisition, merger, tender offer, reorganization, disposition or other
similar material transaction and the Company determines in good faith that (A) the Company’s ability to pursue or consummate
such a material transaction would be materially adversely affected by any required disclosure of such transaction in such
Registration Statement or other registration statement or (B) such material transaction renders the Company unable to comply with
Commission requirements, in each case under circumstances that would make it impractical or inadvisable to cause any Registration
Statement (or such filings) to be used by Investor or to promptly amend or supplement any Registration Statement contemplated by
this Agreement on a post effective basis, as applicable, or (y) has experienced some other material non-public event the disclosure
of which at such time, in the good faith judgment of the Company, would materially adversely affect the Company (each, an
 “Allowable Grace Period”); provided, however, that in no event shall the Investor be suspended from
selling Registrable Securities pursuant to any Registration Statement for a period that exceeds 20 consecutive Trading Days; and provided,
further, the Company shall not effect any such suspension during the five-Trading Day period immediately following each Fixed
Purchase Date, VWAP Purchase Date and Additional VWAP Purchase Date. Upon disclosure of such information or the termination of the
condition described above, the Company shall provide prompt notice, but in any event within one Business Day of such disclosure or
termination, to the Investor and shall promptly terminate any suspension of sales it has put into effect and shall take such other
reasonable actions to permit registered sales of Registrable Securities as contemplated in this Agreement (including as set forth in
the first sentence of Section 3(f) with respect to the information giving rise thereto unless such material, non-public information
is no longer applicable). Notwithstanding anything to the contrary contained in this Section 3(p), the Company shall cause its
transfer agent to deliver DWAC Shares to a transferee of the Investor in accordance with the terms of the Purchase Agreement in
connection with any sale of Registrable Securities with respect to which (i) the Company has made a sale to Investor and (ii) the
Investor has entered into a contract for sale, and delivered a copy of the Prospectus included as part of the particular
Registration Statement to the extent applicable, in each case prior to the Investor’s receipt of the notice of an Allowable
Grace Period and for which the Investor has not yet settled.

 

    11 

     

    

 

		4.	Obligations of the Investor.

 

(a)       At
least five (5) Business Days prior to the first anticipated filing date of each Registration Statement (or such shorter period to which
the parties agree), the Company shall notify the Investor in writing of the information the Company requires from the Investor with respect
to such Registration Statement. It shall be a condition precedent to the obligations of the Company to complete the registration pursuant
to this Agreement with respect to the Registrable Securities of the Investor that the Investor shall furnish to the Company such information
regarding itself, the Registrable Securities held by it and the intended method of disposition of the Registrable Securities held by it,
as shall be reasonably required to effect and maintain the effectiveness of the registration of such Registrable Securities and shall
execute such documents in connection with such registration as the Company may reasonably request.

 

(b)       The
Investor, by its acceptance of the Registrable Securities, agrees to cooperate with the Company as reasonably requested by the Company
in connection with the preparation and filing of each Registration Statement hereunder, unless the Investor has notified the Company in
writing of the Investor’s election to exclude all of the Investor’s Registrable Securities from such Registration Statement.

 

(c)       The
Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section 3(p)
or the first sentence of 3(f), the Investor shall immediately discontinue disposition of Registrable Securities pursuant to any Registration
Statement(s) covering such Registrable Securities until the Investor’s receipt of the copies of the supplemented or amended Prospectus
contemplated by Section 3(p) or the first sentence of Section 3(f) or receipt of notice that no supplement or amendment is required. Notwithstanding
anything to the contrary in this Section 4(c), the Company shall cause its transfer agent to deliver DWAC Shares to a transferee of the
Investor in accordance with the terms of the Purchase Agreement in connection with any sale of Registrable Securities with respect to
which the Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company of the happening
of any event of the kind described in Section 3(p) or the first sentence of Section 3(f) and for which the Investor has not yet settled.

 

(d)       The
Investor covenants and agrees that it shall comply with the prospectus delivery and other requirements of the Securities Act as applicable
to it in connection with sales of Registrable Securities pursuant to a Registration Statement.

 

		5.	Expenses of Registration.

 

All reasonable expenses
of the Company, other than sales or brokerage commissions and fees and disbursements of counsel for, and other expenses of, the
Investor, incurred in connection with registrations, filings or qualifications pursuant to Sections 2 and 3, including, without
limitation, all registration, listing and qualifications fees, printers and accounting fees, and fees and disbursements of counsel
for the Company, shall be paid by the Company.

 

    12 

     

    

 

		6.	Indemnification.

 

(a)       In
the event any Registrable Securities are included in any Registration Statement under this Agreement, to the fullest extent
permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, each of its directors,
officers, shareholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally
equivalent role of a Person holding such titles notwithstanding the lack of such title or any other title) and each Person, if any,
who controls the Investor within the meaning of the Securities Act or the Exchange Act and each of the directors, officers,
shareholders, members, partners, employees, agents, advisors, representatives (and any other Persons with a functionally equivalent
role of a Person holding such titles notwithstanding the lack of such title or any other title) of such controlling Persons (each,
an “Investor Party” and collectively, the “Investor Parties”), against any
losses, obligations, claims, damages, liabilities, contingencies, judgments, fines, penalties, charges, costs (including, without
limitation, court costs, reasonable attorneys’ fees, costs of defense and investigation), amounts paid in settlement or
expenses, joint or several, (collectively, “Claims”) reasonably incurred in investigating, preparing or
defending any action, claim, suit, inquiry, proceeding, investigation or appeal taken from the foregoing by or before any court or
governmental, administrative or other regulatory agency, body or the Commission, whether pending or threatened, whether or not an
Investor Party is or may be a party thereto (“Indemnified Damages”), to which any of them may become
subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect thereof) arise out of or are
based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement or any
post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities or
other “Blue Sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky
Filing”), or the omission or alleged omission to state a material fact required to be stated therein or necessary to
make the statements therein not misleading or (ii) any untrue statement or alleged untrue statement of a material fact contained in
any Prospectus (as amended or supplemented) or in any Prospectus Supplement or the omission or alleged omission to state therein any
material fact necessary to make the statements made therein, in light of the circumstances under which the statements therein were
made, not misleading (the matters in the foregoing clauses (i) and (ii) being, collectively,
 “Violations”). Subject to Section 6(c), the Company shall reimburse the Investor Parties, promptly as such
expenses are incurred and are due and payable, for any legal fees or other reasonable expenses incurred by them in connection with
investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the indemnification agreement
contained in this Section 6(a): (i) shall not apply to a Claim by an Investor Party arising out of or based upon a Violation which
occurs in reliance upon and in conformity with information furnished in writing to the Company by such Investor Party for such
Investor Party expressly for use in connection with the preparation of such Registration Statement, Prospectus or Prospectus
Supplement or any such amendment thereof or supplement thereto (it being hereby acknowledged and agreed that the written information
set forth on Exhibit C attached hereto is the only written information furnished to the Company by or on behalf of the
Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement); (ii) shall not be available to the
Investor to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered the Prospectus (as
amended or supplemented) made available by the Company (to the extent applicable), including, without limitation, a corrected
Prospectus, if such Prospectus (as amended or supplemented) or corrected Prospectus was timely made available by the Company
pursuant to Section 3(d) and then only if, and to the extent that, following the receipt of the corrected Prospectus no grounds for
such Claim would have existed; and (iii) shall not apply to amounts paid in settlement of any Claim if such settlement is effected
without the prior written consent of the Company, which consent shall not be unreasonably withheld or delayed. Such indemnity shall
remain in full force and effect regardless of any investigation made by or on behalf of the Investor Party and shall survive the
transfer of any of the Registrable Securities by the Investor pursuant to Section 9.

 

    13 

     

    

 

(b)       In
connection with any Registration Statement in which the Investor is participating, the Investor agrees to severally and not jointly indemnify,
hold harmless and defend, to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors,
each of its officers who signs the Registration Statement and each Person, if any, who controls the Company within the meaning of the
Securities Act or the Exchange Act (each, an “Company Party”), against any Claim or Indemnified Damages to which
any of them may become subject, under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified Damages
arise out of or are based upon any Violation, in each case, to the extent, and only to the extent, that such Violation occurs in reliance
upon and in conformity with written information relating to the Investor furnished to the Company by the Investor expressly for use in
connection with such Registration Statement, the Prospectus included therein or any Prospectus Supplement thereto (it being hereby acknowledged
and agreed that the written information set forth on Exhibit C attached hereto is the only written information furnished to the
Company by or on behalf of the Investor expressly for use in any Registration Statement, Prospectus or Prospectus Supplement); and, subject
to Section 6(c) and the below provisos in this Section 6(b), the Investor shall reimburse a Company Party any legal or other expenses
reasonably incurred by such Company Party in connection with investigating or defending any such Claim; provided, however,
the indemnity agreement contained in this Section 6(b) and the agreement with respect to contribution contained in Section 7 shall not
apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent of the Investor, which
consent shall not be unreasonably withheld or delayed; and provided, further that the Investor shall be liable under this Section
6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to the Investor as a result of the applicable
sale of Registrable Securities pursuant to such Registration Statement, Prospectus or Prospectus Supplement. Such indemnity shall remain
in full force and effect regardless of any investigation made by or on behalf of such Company Party and shall survive the transfer of
any of the Registrable Securities by the Investor pursuant to Section 9.

 

    14 

     

    

 

(c)       Promptly
after receipt by an Investor Party or Company Party (as the case may be) under this Section 6 of notice of the commencement of any
action or proceeding (including, without limitation, any governmental action or proceeding) involving a Claim, such Investor Party
or Company Party (as the case may be) shall, if a Claim in respect thereof is to be made against any indemnifying party under this
Section 6, deliver to the indemnifying party a written notice of the commencement thereof, and the indemnifying party shall have the
right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party similarly
noticed, to assume control of the defense thereof with counsel mutually satisfactory to the indemnifying party and the Investor
Party or the Company Party (as the case may be); provided, however, an Investor Party or Company Party (as the case
may be) shall have the right to retain its own counsel with the fees and expenses of such counsel to be paid by the indemnifying
party if: (i) the indemnifying party has agreed in writing to pay such fees and expenses; (ii) the indemnifying party shall have
failed promptly to assume the defense of such Claim and to employ counsel reasonably satisfactory to such Investor Party or Company
Party (as the case may be) in any such Claim; or (iii) the named parties to any such Claim (including, without limitation, any
impleaded parties) include both such Investor Party or Company Party (as the case may be) and the indemnifying party, and such
Investor Party or such Company Party (as the case may be) shall have been advised by counsel that a conflict of interest is likely
to exist if the same counsel were to represent such Investor Party or such Company Party and the indemnifying party (in which case,
if such Investor Party or such Company Party (as the case may be) notifies the indemnifying party in writing that it elects to
employ separate counsel at the expense of the indemnifying party, then the indemnifying party shall not have the right to assume the
defense thereof on behalf of the indemnified party and such counsel shall be at the expense of the indemnifying party, provided
further that in the case of clause (iii) above the indemnifying party shall not be responsible for the reasonable fees and
expenses of more than one (1) separate legal counsel for all Investor Parties or Company Parties (as the case may be)). The Company
Party or Investor Party (as the case may be) shall reasonably cooperate with the indemnifying party in connection with any
negotiation or defense of any such action or Claim by the indemnifying party and shall furnish to the indemnifying party all
information reasonably available to the Company Party or Investor Party (as the case may be) which relates to such action or Claim.
The indemnifying party shall keep the Company Party or Investor Party (as the case may be) reasonably apprised at all times as to
the status of the defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any
settlement of any action, claim or proceeding effected without its prior written consent; provided, however, the
indemnifying party shall not unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior
written consent of the Company Party or Investor Party (as the case may be), consent to entry of any judgment or enter into any
settlement or other compromise which does not include as an unconditional term thereof the giving by the claimant or plaintiff to
such Company Party or Investor Party (as the case may be) of a release from all liability in respect to such Claim or litigation,
and such settlement shall not include any admission as to fault on the part of the Company Party. For the avoidance of doubt, the
immediately preceding sentence shall apply to Sections 6(a) and 6(b) hereof. Following indemnification as provided for hereunder,
the indemnifying party shall be subrogated to all rights of the Company Party or Investor Party (as the case may be) with respect to
all third parties, firms or corporations relating to the matter for which indemnification has been made. The failure to deliver
written notice to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such
indemnifying party of any liability to the Investor Party or Company Party (as the case may be) under this Section 6, except to the
extent that the indemnifying party is materially and adversely prejudiced in its ability to defend such action.

 

(d)       No
Person involved in the sale of Registrable Securities who is guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) in connection with such sale shall be entitled to indemnification from any Person involved in such sale of Registrable
Securities who is not guilty of fraudulent misrepresentation.

 

(e)       The
indemnification required by this Section 6 shall be made by periodic payments of the amount thereof during the course of the
investigation or defense, as and when bills are received or Indemnified Damages are incurred; provided that any Person
receiving any payment pursuant to this Section 6 shall promptly reimburse the Person making such payment for the amount of such
payment to the extent a court of competent jurisdiction determines that such Person receiving such payment was not entitled to such
payment.

 

    15 

     

    

 

(f)       The
indemnity and contribution agreements contained herein shall be in addition to (i) any cause of action or similar right of the Company
Party or Investor Party against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to pursuant
to the law.

 

		7.	Contribution.

 

To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law; provided, however:
(i) no contribution shall be made under circumstances where the maker would not have been liable for indemnification under the fault standards
set forth in Section 6 of this Agreement, (ii) no Person involved in the sale of Registrable Securities which Person is guilty of fraudulent
misrepresentation (within the meaning of Section 11(f) of the Securities Act) in connection with such sale shall be entitled to contribution
from any Person involved in such sale of Registrable Securities who was not guilty of fraudulent misrepresentation; and (iii) contribution
by any seller of Registrable Securities shall be limited in amount to the amount of net proceeds received by such seller from the applicable
sale of such Registrable Securities pursuant to such Registration Statement. Notwithstanding the provisions of this Section 7, the Investor
shall not be required to contribute, in the aggregate, any amount in excess of the amount by which the net proceeds actually received
by the Investor from the applicable sale of the Registrable Securities subject to the Claim exceeds the amount of any damages that the
Investor has otherwise been required to pay, or would otherwise be required to pay under Section 6(b), by reason of such untrue or alleged
untrue statement or omission or alleged omission.

 

		8.	Reports Under the Exchange Act.

 

With a view to making available
to the Investor the benefits of Rule 144, the Company agrees to:

 

(a)       use
its reasonable best efforts to make and keep public information available, as those terms are understood and defined in Rule 144;

 

(b)       use
its reasonable best efforts to file with the Commission in a timely manner all reports and other documents required of the Company under
the Securities Act and the Exchange Act so long as the Company remains subject to such requirements (it being understood that nothing
herein shall limit any of the Company’s obligations under the Purchase Agreement) and the filing of such reports and other documents
is required for the applicable provisions of Rule 144;

 

(c)       furnish
to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written statement by the Company,
if true, that it has complied with the reporting, submission and posting requirements of Rule 144 and the Exchange Act, (ii) a copy
of the most recent annual or quarterly report of the Company and such other reports and documents so filed by the Company with the
Commission if such reports are not publicly available via EDGAR, and (iii) such other information as may be reasonably requested to
permit the Investor to sell such securities pursuant to Rule 144 without registration; and

 

    16 

     

    

 

 

(d)       take
such additional action as is reasonably requested by the Investor to enable the Investor to sell the Registrable Securities pursuant to
Rule 144, including, without limitation, delivering all such legal opinions, consents, certificates, resolutions and instructions to the
Company’s Transfer Agent as may be reasonably requested from time to time by the Investor and otherwise fully cooperate with Investor
and Investor’s broker to effect such sale of securities pursuant to Rule 144.

 

		9.	Assignment of Registration Rights.

 

The Company shall not assign
this Agreement or any rights or obligations hereunder without the prior written consent of the Investor; provided, however, that any transaction,
whether by merger, reorganization, restructuring, consolidation, financing or otherwise, whereby the Company remains the surviving entity
immediately after such transaction shall not be deemed an assignment. The Investor may not assign its rights under this Agreement, other
than to an affiliate of the Investor controlled by Marissa J. Welner, in which case the assignee must agree in writing to be bound by
the terms and conditions of this Agreement.

 

		10.	Amendment or Waiver.

 

No provision of this Agreement
may be amended or waived by the parties from and after the date that is one (1) Trading Day immediately preceding the filing of the Initial
Registration Statement with the Commission. Subject to the immediately preceding sentence, no provision of this Agreement may be (i) amended
other than by a written instrument signed by both parties hereto or (ii) waived other than in a written instrument signed by the party
against whom enforcement of such waiver is sought. Failure of any party to exercise any right or remedy under this Agreement or otherwise,
or delay by a party in exercising such right or remedy, shall not operate as a waiver thereof.

 

		11.	Miscellaneous.

 

(a)       Solely
for purposes of this Agreement, a Person is deemed to be a holder of Registrable Securities whenever such Person owns or is deemed to
own of record such Registrable Securities. If the Company receives conflicting instructions, notices or elections from two or more Persons
with respect to the same Registrable Securities, the Company shall act upon the basis of instructions, notice or election received from
such record owner of such Registrable Securities.

 

(b)       Any
notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement shall be given
in accordance with Section 10.4 of the Purchase Agreement.

 

(c)       Failure
of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such right or
remedy, shall not operate as a waiver thereof. The Company and the Investor acknowledge and agree that irreparable damage would
occur in the event that any of the provisions of this Agreement were not performed in accordance with their specific terms or were
otherwise breached. It is accordingly agreed that either party shall be entitled to an injunction or injunctions to prevent or cure
breaches of the provisions of this Agreement by the other party and to enforce specifically the terms and provisions hereof (without
the necessity of showing economic loss and without any bond or other security being required), this being in addition to any other
remedy to which either party may be entitled by law or equity.

 

    17

     

    

 

(d)       All
questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be governed by the internal laws
of the State of New York, without giving effect to any choice of law or conflict of law provision or rule (whether of the State of New
York or any other jurisdictions) that would cause the application of the laws of any jurisdictions other than the State of New York. Each
party hereby irrevocably submits to the exclusive jurisdiction of the federal courts sitting in The City of New York, Borough of Manhattan,
for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein,
and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such
suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to process being
served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices to it under this
Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any manner permitted by law. If any provision of this Agreement shall
be invalid or unenforceable in any jurisdiction, such invalidity or unenforceability shall not affect the validity or enforceability of
the remainder of this Agreement in that jurisdiction or the validity or enforceability of any provision of this Agreement in any other
jurisdiction. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION
OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

(e)       The
Transaction Documents set forth the entire agreement and understanding of the parties solely with respect to the subject matter thereof
and supersedes all prior and contemporaneous agreements, negotiations and understandings between the parties, both oral and written, solely
with respect to such matters. There are no promises, undertakings, representations or warranties by either party relative to subject matter
hereof not expressly set forth in the Transaction Documents. Notwithstanding anything in this Agreement to the contrary and without implication
that the contrary would otherwise be true, nothing contained in this Agreement shall limit, modify or affect in any manner whatsoever
(i) the conditions precedent to a Fixed Purchase, a VWAP Purchase and an Additional VWAP Purchase contained in Article VII of the Purchase
Agreement or (ii) any of the Company’s obligations under the Purchase Agreement.

 

(f)       This
Agreement shall inure to the benefit of and be binding upon the parties hereto and their respective successors. This Agreement is not
for the benefit of, nor may any provision hereof be enforced by, any Person, other than the parties hereto, their respective successors
and the Persons referred to in Sections 6 and 7 hereof.

 

(g)       The
headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof. Unless the
context clearly indicates otherwise, each pronoun herein shall be deemed to include the masculine, feminine, neuter, singular and plural
forms thereof. The terms “including,” “includes,” “include” and words of like import shall be construed
broadly as if followed by the words “without limitation.” The terms “herein,” “hereunder,” “hereof”
and words of like import refer to this entire Agreement instead of just the provision in which they are found.

 

(h)       This
Agreement may be executed in two or more identical counterparts, all of which shall be considered one and the same agreement and shall
become effective when counterparts have been signed by each party and delivered to the other party; provided that a facsimile signature
or signature delivered by e-mail in a “.pdf” format data file, including any electronic signature complying with the U.S.
federal ESIGN Act of 2000, e.g., www.docusign.com, www.echosign.adobe.com, etc., shall be considered due execution and shall be binding
upon the signatory thereto with the same force and effect as if the signature were an original signature.

 

(i)       Each
party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver all such
other agreements, certificates, instruments and documents as any other party may reasonably request in order to carry out the intent and
accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(j)       The
language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and no rules of
strict construction will be applied against any party.

 

[Signature Pages Follow]

 

    18

     

    

 

IN WITNESS WHEREOF,
Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the
date first written above.

 

	 	
    COMPANY:

     

    ASHFORD HOSPITALITY TRUST, INC.

	 	 
	 	 
	 	By:	/s/ J. Robison Hays, III
	 	 	Name:	J. Robison Hays, III
	 	 	Title:	President and Chief Executive Officer

 

    19

     

    

 

IN WITNESS WHEREOF,
Investor and the Company have caused their respective signature page to this Registration Rights Agreement to be duly executed as of the
date first written above.

 

	 	
    INVESTOR:

     

    SEVEN KNOTS, LLC

	 	 
	 	 
	 	By:	/s/ Marissa J. Welner
	 	 	Name:	Marissa J. Welner
	 	 	Title:	Managing Member

 

    20

     

    

 

EXHIBIT A

 

FORM OF NOTICE
OF EFFECTIVENESS

OF REGISTRATION STATEMENT

 

 

 

Computershare Trust Company, N.A.

222 N. Pacific Coast Highway, 3rd Floor

El Segundo, CA 90245

Attention: Bridget Huerta

 

Re:      Ashford Hospitality Trust, Inc.

 

Ladies and Gentlemen:

 

We are counsel to Ashford
Hospitality Trust, Inc., a Maryland corporation (the “Company”), and have represented the Company in connection
with that certain Common Stock Purchase Agreement, dated June 18, 2021 (the “Purchase Agreement”), entered into
by and among the Company, Ashford Hospitality Limited Partnership, a Delaware limited partnership, and the Investor named therein (the
 “Holder”), pursuant to which the Company will issue to the Holder from time to time
up to 40,093,080 shares of the Company’s common stock, par value $0.01 per share (the ”Common
Stock”). Pursuant to the Purchase Agreement, the Company also has entered into a Registration Rights Agreement, dated June
18, 2021, with the Holder (the “Registration Rights Agreement”), pursuant to which the Company agreed, among
other things, to register the offer and sale by the Holder of the Registrable Securities (as defined in the Registration Rights Agreement)
under the Securities Act of 1933, as amended (the “Securities Act”). In connection with the Company’s
obligations under the Registration Rights Agreement, on [●], 202[●], the Company filed a Registration Statement on Form S-11
(File No. 333-[●]) (the “Registration Statement”) with the Securities and Exchange Commission (the “Commission”)
relating to the Registrable Securities which names the Holder as an underwriter and a selling stockholder thereunder.

 

In
connection with the foregoing, based solely on our review of the Commission’s EDGAR website, we advise you that the Registration
Statement became effective under the Securities Act on [●], 202[●].
In addition, based solely on our review of the information made available by the Commission at http://www.sec.gov/litigation/stoporders.shtml,
we confirm that the Commission has not issued any stop order suspending the effectiveness of the Registration Statement. To our knowledge,
based solely on our participation in the conferences mentioned above regarding the Registration Statement and our review of the information
made available by the Commission at http://www.sec.gov/litigation/stoporders.shtml, no proceedings for that purpose are pending or have
been instituted or threatened by the Commission.

 

This letter shall serve as
our standing opinion to you that the shares of Common Stock are freely transferable by the Holder pursuant to the Registration Statement,
provided the Registration Statement remains effective.

 

This opinion letter is limited
to the federal securities laws of the United States of America. We express no opinion as to matters relating to state securities laws
or Blue Sky laws.

 

We assume no obligation to
update or supplement this opinion letter to reflect any facts or circumstances which may hereafter come to our attention with respect
to the opinion and statements expressed above, including any changes in applicable law that may hereafter occur.

 

This opinion letter is being
delivered solely for the benefit of the person to whom it is addressed; accordingly, it may not be quoted, filed with any governmental
authority or other regulatory agency or otherwise circulated or utilized for any purposes without our prior written consent.

 

	 	Very truly yours,
	 	 
	 	[ISSUER’S COUNSEL]
	 	 
	 	By:	 
	
    cc: Seven Knots, LLC

    
	 

 

    

     

    

 

EXHIBIT B

 

SELLING STOCKHOLDER

 

This prospectus relates to
the possible resale from time to time by Seven Knots of any or all of the shares of common stock that may be issued by us to Seven Knots
under the Purchase Agreement. For additional information regarding the issuance of common stock covered by this prospectus, see the section
titled “Seven Knots Committed Equity Financing” above. We are registering the shares of common stock pursuant to the provisions
of the Registration Rights Agreement we entered into with Seven Knots on June 18, 2021 in order to permit the selling stockholder to offer
the shares for resale from time to time. Except for the transactions contemplated by the Purchase Agreement and the Registration Rights
Agreement, Seven Knots has not had any material relationship with us within the past three years. As used in this prospectus, the term
 “selling stockholder” means Seven Knots, LLC.

 

The table below presents information
regarding the selling stockholder and the shares of common stock that it may offer from time to time under this prospectus. This table
is prepared based on information supplied to us by the selling stockholder, and reflects holdings as of June 18, 2021. The number of shares
in the column “Maximum Number of Shares of Common Stock to be Offered Pursuant to this Prospectus” represents all of the shares
of common stock that the selling stockholder may offer under this prospectus. The selling stockholder may sell some, all or none of its
shares in this offering. We do not know how long the selling stockholder will hold the shares before selling them, and we currently have
no agreements, arrangements or understandings with the selling stockholder regarding the sale of any of the shares.

 

Beneficial ownership is determined
in accordance with Rule 13d-3(d) promulgated by the SEC under the Exchange Act, and includes shares of common stock with respect to which
the selling stockholder has voting and investment power. The percentage of shares of common stock beneficially owned by the selling stockholder
prior to the offering shown in the table below is based on an aggregate of 200,565,683 shares of our common stock outstanding on June
18, 2021, 2021. Because the purchase price for the shares of common stock we may direct Seven Knots to purchase under the Purchase Agreement
is determined on the applicable Fixed Purchase Date with respect to a Fixed Purchase, on the applicable VWAP Purchase Date with respect
to a VWAP Purchase, and on the applicable Additional VWAP Purchase Date with respect to an Additional VWAP Purchase, the number of shares
that may actually be sold by the Company to Seven Knots under the Purchase Agreement may be fewer than the number of shares being offered
by this prospectus. The fourth column assumes the sale of all of the shares offered by the selling stockholder pursuant to this prospectus.

 

    

     

    

 

	Name of Selling Stockholder	 	Number
    of Shares of

 Common Stock Owned 

Prior to Offering	 	 	Maximum
    Number of 

Shares of Common Stock

 to be Offered Pursuant to

 this Prospectus	 	 	Number
    of Shares of 

Common Stock Owned 

After Offering	 
	 	 	 	Number(1)	 	 	 	Percent(2)	 	 	 	 	 	 		Number(3)	 	 	 	Percent(2)	 
	Seven Knots, LLC(4)	 	 	0	 	 	 	*	 	 	 	40,093,080	 	 	 	0	 	 	 	--	 

 

 

 

* Represents
beneficial ownership of less than 1% of the outstanding shares of our common stock.

 

		(1)	In accordance with Rule 13d-3(d) under the Exchange Act, we have excluded from the number of shares beneficially
owned prior to the offering all of the shares of common stock that Seven Knots may be required to purchase under the Purchase Agreement,
because the issuance of such shares is solely at our discretion and is subject to conditions contained in the Purchase Agreement, the
satisfaction of which are entirely outside of Seven Knot’s control, including the registration statement that includes this prospectus
becoming and remaining effective. Furthermore, the Fixed Purchases, VWAP Purchases and Additional VWAP Purchases of common stock are subject
to certain agreed upon maximum amount limitations set forth in the Purchase Agreement. Also, the Purchase Agreement prohibits us from
issuing and selling any shares of our common stock to Seven Knots to the extent such shares, when aggregated with all other shares of
our common stock then beneficially owned by Seven Knots, would cause Seven Knots’s beneficial ownership of our common stock to exceed
the 4.99% Beneficial Ownership Cap. The Purchase Agreement also prohibits us from issuing or selling to Seven Knots more than a total
of 40,093,080 shares of our common stock, including shares of common stock that we may elect to sell to Seven Knots under the Purchase
Agreement from and after the date of this prospectus, which total number of shares equals 19.99% of the shares of our common stock that
were issued and outstanding immediately prior to our execution of the Purchase Agreement. None of the foregoing share issuance limitations
may be amended or waived by the parties under the Purchase Agreement.

 

		(2)	Applicable percentage ownership is based on 200,565,683 shares of our common stock outstanding as of June
18, 2021.

 

		(3)	Assumes the sale of all shares being offered pursuant to this prospectus.

 

		(4)	The business address of Seven Knots, LLC is 7 Rose Avenue, Great Neck, New York, 11021. Seven Knots, LLC’s
principal business is that of a private investor. Marissa J. Welner is the beneficial owner of 50% of the membership interests in Seven
Knots LLC. Ms. Welner has sole voting control and investment discretion over securities beneficially owned directly by Seven Knots, LLC.
We have been advised that neither Ms. Welner nor Seven Knots LLC is a member of the Financial Industry Regulatory Authority, or FINRA,
or an independent broker-dealer, or an affiliate or associated person of a FINRA member or independent broker-dealer. The foregoing should
not be construed in and of itself as an admission by Ms. Welner as to beneficial ownership of the securities beneficially owned directly
by Seven Knots, LLC.

 

    

     

    

 

PLAN OF DISTRIBUTION

 

The shares of common stock
offered by this prospectus are being offered by the selling stockholder, Seven Knots, LLC.  The shares may be sold or distributed
from time to time by the selling stockholder directly to one or more purchasers or through brokers, dealers, or underwriters who may act
solely as agents at market prices prevailing at the time of sale, at prices related to the prevailing market prices, at negotiated prices,
or at fixed prices, which may be changed. The sale of the shares of our common stock offered by this prospectus could be effected in one
or more of the following methods:

 

		·	ordinary brokers’ transactions; 

 

		·	transactions involving cross or block trades; 

 

		·	through brokers, dealers, or underwriters who may act solely as agents; 

 

		·	“at the market” into an existing market for our common stock; 

 

		·	in other ways not involving market makers or established business markets, including direct sales to purchasers
or sales effected through agents; 

 

		·	in privately negotiated transactions; or 

 

		·	any combination of the foregoing. 

 

In order to comply with the
securities laws of certain states, if applicable, the shares may be sold only through registered or licensed brokers or dealers. In addition,
in certain states, the shares may not be sold unless they have been registered or qualified for sale in the state or an exemption from
the state’s registration or qualification requirement is available and complied with.

 

Seven Knots is an “underwriter”
within the meaning of Section 2(a)(11) of the Securities Act.

 

Seven Knots has informed us
that it intends to use one or more registered broker-dealers to effectuate all sales, if any, of our common stock that it has acquired
and may in the future acquire from us pursuant to the Purchase Agreement.  Such sales will be made at prices and at terms then prevailing
or at prices related to the then current market price.  Each such registered broker-dealer will be an underwriter within the meaning
of Section 2(a)(11) of the Securities Act.  Seven Knots has informed us that each such broker-dealer will receive commissions from
Seven Knots that will not exceed customary brokerage commissions.

 

Brokers, dealers,
underwriters or agents participating in the distribution of the shares of our common stock offered by this prospectus may receive
compensation in the form of commissions, discounts, or concessions from the purchasers, for whom the broker-dealers may act as
agent. The compensation paid to any such particular broker-dealer by any such purchasers of shares of our common stock sold by the
selling stockholder may be less than or in excess of customary commissions.  Neither we nor the selling stockholder can
presently estimate the amount of compensation that any agent will receive from any purchasers of shares of our common stock sold by
the selling stockholder.

 

    

     

    

 

We know of no existing arrangements
between the selling stockholder or any other stockholder, broker, dealer, underwriter or agent relating to the sale or distribution of
the shares of our common stock offered by this prospectus.

 

We may from time to time file
with the SEC one or more supplements to this prospectus or amendments to the registration statement of which this prospectus forms a part
to amend, supplement or update information contained in this prospectus, including, if and when required under the Securities Act, to
disclose certain information relating to a particular sale of shares offered by this prospectus by the selling stockholder, including
the names of any brokers, dealers, underwriters or agents participating in the distribution of such shares by the selling stockholder,
any compensation paid by the selling stockholder to any such brokers, dealers, underwriters or agents, and any other required information.

 

We will pay the expenses incident
to the registration under the Securities Act of the offer and sale of the shares of our common stock covered by this prospectus by the
selling stockholder. We also paid to Seven Knots $35,000 in cash as reimbursement to Seven Knots for the reasonable out-of-pocket expenses
incurred by Seven Knots, including the legal fees and disbursements of Seven Knot’s legal counsel, in connection with its due diligence
investigation of the Company and in connection with the preparation, negotiation and execution of the Purchase Agreement.

 

We also have agreed to indemnify
Seven Knots and certain other persons against certain liabilities in connection with the offering of shares of our common stock offered
hereby, including liabilities arising under the Securities Act or, if such indemnity is unavailable, to contribute amounts required to
be paid in respect of such liabilities.  Seven Knots has agreed to indemnify us against liabilities under the Securities Act that
may arise from certain written information furnished to us by Seven Knots specifically for use in this prospectus or, if such indemnity
is unavailable, to contribute amounts required to be paid in respect of such liabilities. Insofar as indemnification for liabilities arising
under the Securities Act may be permitted to our directors, officers, and controlling persons, we have been advised that in the opinion
of the SEC this indemnification is against public policy as expressed in the Securities Act and is therefore, unenforceable.

 

We estimate that the total
expenses for the offering will be approximately $[●].

 

Seven Knots has represented
to us that at no time prior to the date of the Purchase Agreement has Seven Knots or its agents, representatives or affiliates engaged
in or effected, in any manner whatsoever, directly or indirectly, any short sale (as such term is defined in Rule 200 of Regulation SHO
of the Exchange Act) of our common stock or any hedging transaction, which establishes a net short position with respect to our common
stock.  Seven Knots has agreed that during the term of the Purchase Agreement, neither Seven Knots, nor any of its agents, representatives
or affiliates will enter into or effect, directly or indirectly, any of the foregoing transactions.

 

We have advised the
selling stockholder that it is required to comply with Regulation M promulgated under the Exchange Act. With certain exceptions,
Regulation M precludes the selling stockholder, any affiliated purchasers, and any broker-dealer or other person who participates in
the distribution from bidding for or purchasing, or attempting to induce any person to bid for or purchase any security which is the
subject of the distribution until the entire distribution is complete. Regulation M also prohibits any bids or purchases made in
order to stabilize the price of a security in connection with the distribution of that security. All of the foregoing may affect the
marketability of the securities offered by this prospectus.

 

This offering will terminate
on the date that all shares of our common stock offered by this prospectus have been sold by the selling stockholder.

 

Our common stock is currently
listed on the NYSE under the symbol “AHT”.

 

    

     

    

 

EXHIBIT C

 

The business address of Seven Knots, LLC is 7
Rose Avenue, Great Neck, New York, 11021. Seven Knots, LLC’s principal business is that of a private investor. Marissa J. Welner
is the beneficial owner of 50% of the membership interests in Seven Knots LLC. Marissa J. Welner has sole voting control and investment
discretion over securities beneficially owned directly by Seven Knots, LLC. We have been advised that neither Ms. Welner nor Seven Knots
LLC is a member of the Financial Industry Regulatory Authority, or FINRA, or an independent broker-dealer, or an affiliate or associated
person of a FINRA member or independent broker-dealer. The foregoing should not be construed in and of itself as an admission by Ms. Welner
as to beneficial ownership of the securities beneficially owned directly by Seven Knots, LLC.EX-10.4

 Exhibit 10.4 

INTEGRAL AD SCIENCE HOLDING CORP. 

OPTION AWARD NOTICE 

Pursuant to the terms and conditions of the Integral Ad Science Holding Corp. 2021 Omnibus Incentive Plan, as amended from time to time
(the “Plan”), Integral Ad Science Holding Corp., a Delaware corporation (the “Company”), hereby grants to the individual listed below (“you” or the “Participant”) an award of Stock
Options to purchase a number of Shares set forth below (the “Options”). Each Option represents the right to purchase one Share. This award of Options (this “Award”) is subject to the terms and conditions set
forth herein and in the Option Award Agreement attached hereto as Exhibit A, including the additional terms and conditions for certain countries, as set forth in the appendix attached thereto (the
“Appendix” and, together, the “Agreement”) and the Plan, each of which is incorporated herein by reference. Capitalized terms used herein without definition have the meanings ascribed to such terms in the Plan. 

 

			
	Type of Award:	  	Nonqualified Stock Option under Article VI of the Plan.
		
	Participant:	  	[•]
		
	Grant Date:	  	[•]
		
	Total Number of Shares Subject to the Options:	  	[•]
		
	Exercise Price per Share	  	USD [•]
		
	Expiration Date	  	[•]

 By your signature below, you agree to be bound by the terms and conditions of the Plan, the Agreement, and
this Option Award Notice (this “Grant Notice”). You acknowledge that you have reviewed the Agreement, the Plan, and this Grant Notice in their entirety and fully understand all provisions of the Agreement, the Plan, and this Grant
Notice. You hereby agree to accept as binding, conclusive, and final all decisions or interpretations of the Committee regarding any questions or determinations that arise under the Agreement, the Plan, or this Grant Notice. This Grant Notice may be
executed in one or more counterparts (including portable document format (.pdf) and facsimile counterparts), each of which shall be deemed to be an original, but all of which taken together shall constitute one and the same agreement. 

[Signature Page Follows] 

 IN WITNESS WHEREOF, the parties hereto have executed this Grant Notice as of the date first
written above. 
  

			
	 INTEGRAL AD SCIENCE HOLDING CORP.
  

	By:	 	              

	Name:	 	[Name]
	Title:	 	[Title]
	  

         

	[Participant]

 [Signature Page to Option Award Notice] 

 INTEGRAL AD SCIENCE HOLDING CORP. 

OPTION AWARD AGREEMENT 

THIS OPTION AWARD AGREEMENT (this “Agreement”) is entered into by and between the Company and the Participant as of the Grant
Date set forth in the Grant Notice to which this Agreement is attached. Capitalized terms used herein without definition have the meanings ascribed to such terms in the Plan. 

WHEREAS, the Plan provides for the grant of Stock Options; and 

WHEREAS, the Committee has determined that it would be in the best interests of the Company and its members to grant the Participant an award
of Options on the terms and subject to the conditions set forth in this Agreement and the Plan. 
 NOW THEREFORE, for and in consideration
of the premises and the covenants of the parties contained in this Agreement, and for other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereto, for themselves and their successors and
assigns, hereby agree as follows: 
 1. Grant of Options. 

(a) Grant. The Company hereby grants to the Participant the number of Options set forth in the Grant Notice on the terms and conditions
set forth in the Grant Notice, this Agreement, and the Plan. Each Option represents the right to purchase one Share. 
 (b) Incorporation
by Reference. The provisions of the Plan are incorporated herein by reference. Except as otherwise expressly set forth herein, this Agreement shall be construed in accordance with the provisions of the Plan. 

2. Vesting. 
 (a) Two
thirds (2⁄3) of the Options (the “Service Options”) shall vest and become exercisable with respect to twenty-five percent (25%) of the Service
Options on each of the first four (4) anniversaries of the Grant Date, subject to the Participant not incurring a Separation from Service prior to the applicable vesting date. 

(b) The remaining one third (1⁄3) of the Options (the
“Return Target Options”) will vest and become exercisable if (A) Participant is, and has been, continuously employed by the Company or its Subsidiaries from the date of Agreement through the date of a Change in Control and
(B) if upon the consummation of such Change in Control, the cumulative total of all cash distributions made to, or other cash proceeds received by, the Investor Fund (as defined below) (excluding management or transaction fees and expenses, any
other advisory fees and expenses, any board fees and expenses or any other expenses borne by the Investor Fund) in respect of its ownership of equity or debt securities of the Company or any of its Subsidiaries or any loans provided by the Investor
Fund during the life of the Investor Fund’s investment period, equals or exceeds the Investor Returns Target (as defined below) (the “Vesting Condition”). 

 (c) As used in this Agreement, (i) the term “Investor Fund” shall mean
one or more equity buy-out investment funds (including Vista Equity Partners Fund VI, L.P.) managed or controlled by VEPF Management, L.P. or any successor management company, and any of such fund’s
respective portfolio companies, (excluding the Company and its Subsidiaries) and their respective partners, members, directors, employees, stockholders, agents, any successor by operation of law (including by merger) of any such Person, and any
entity that acquires all or substantially all of the assets of any such Person in a single transaction or series of related transactions and (ii) the term “Investor Returns Target” shall mean $1,170,000,000. For purposes of
calculating distributions and proceeds under clause (B) immediately above, all distributions made to the Investor Fund will be net of all accrued but unpaid management fees, all expenses associated with the ultimate sale of the Company business
borne by the Investor Fund, and assuming, for purposes of the calculation made above, the vesting (and exercise, if applicable) (prior to the calculation of distributions and proceeds under clause (B) immediately above) of all outstanding
options, warrants and other outstanding rights to acquire capital stock of the Company. For the avoidance of doubt, the Return Target Options shall expire, and shall not vest or become exercisable, if the Vesting Condition has not been satisfied as
of the date of a Change in Control. 
 (d) Notwithstanding anything to the contrary in the Plan, as used in this Agreement, (i) the
term “Change in Control” means the first to occur of (A) the Sale of the Company (as defined below), (B) the sale or transfer to any third party of Common Stock or shares of the capital stock of any Subsidiary by the holders
thereof as a result of which any Person or group other than the Investors (as defined below) obtains possession of voting power (under ordinary circumstances) to elect a majority of the Company’s board of managers or the board of directors or
any other governing body of the applicable Subsidiary, or (C) at any time following the Company’s initial public offering, a sale of shares of the Company by the Investor following which the cumulative total of all cash distributions made
to, or other cash proceeds received by, the Investor Fund (excluding management or transaction fees and expenses, any other advisory fees and expenses, any board fees and expenses or any other expenses borne by the Investor Fund) in respect of its
ownership of equity or debt securities of the Company or any of its Subsidiaries or any loans provided by the Investor Fund during the life of the Investor Fund’s investment period, equals or exceeds the Investor Returns Target; provided that,
for purposes of calculating distributions and proceeds under this clause (C), all distributions made to the Investor Fund will be net of all accrued but unpaid management fees, all expenses associated with the Sale of the Company borne by the
Investor Fund, and assuming, for purposes of the calculation made above, the vesting (and exercise, if applicable) (prior to the calculation of the Investor Return) of all outstanding options, warrants and other outstanding rights to acquire capital
stock of the Company; (ii) the term “Sale of the Company” means (A) any sale or transfer by the Company or any of the Subsidiaries of all or substantially all (as defined under Delaware law) of their assets on a
consolidated basis, or (B) any consolidation, merger or reorganization of the Company or any of its Subsidiaries with or into any other entity or entities as a result of which any Person or group other than the Investors obtains possession of
voting power (under ordinary circumstances) to elect a majority of the surviving entity’s board of directors or, in the case of a surviving entity which is not a corporation, governing body; and (iii) the term “Investors”
means Vista Equity Partners Fund VI, L.P., Vista Equity Partners Fund VI-A, L.P., VEPF VI FAF, L.P. and/or any transferee of Vista Equity Partners Fund VI, L.P., Vista Equity Partners Fund VI-A, L.P., VEPF VI FAF, L.P. and any Affiliate of any of the foregoing Persons that holds Common Stock. 

 3. Exercise of the Option. 

(a) Right to Exercise. The Options shall be exercisable in accordance with the terms set forth in this Agreement. The Options, to the
extent exercisable, may be exercised in whole or in part. No Option may be exercised after it expires. No Shares will be issued upon the exercise of any Option unless the issuance and exercise comply with all Applicable Laws. For income tax
purposes, Shares will be considered transferred to the Participant on the date the Participant properly exercises an Option. No fraction of a Share shall be issued by the Company upon exercise of the Options or accepted by the Company in payment of
the Exercise Price; rather, the Participant shall provide a cash payment for such amount as is necessary to effect the issuance and acceptance of only whole Shares. 

(b) Method of Exercise. The Participant may exercise the Options by delivering an exercise notice in a form approved by the Company
(the “Exercise Notice”). The Exercise Notice must state the Participant’s election to exercise the Options, the number of Shares that are being purchased, and any other representations and agreements that may be required by the
Company. Together with the Exercise Notice, the Participant must tender payment of the aggregate Exercise Price for all Shares exercised and all applicable withholding and other taxes. The Options shall be deemed to be exercised upon receipt by the
Company of a fully executed Exercise Notice and payment of the aggregate Exercise Price and all applicable withholding and other taxes. 

(c) Method of Payment. If the Participant elects to exercise the Options, the Participant must pay the aggregate Exercise Price, as
well as any applicable withholding or other taxes, in accordance with any of the payment methods set forth in, and approved by the Committee pursuant to, Section 6.3(d) of the Plan (or any successor sections). The Company may suspend, or
eliminate, various forms of permissible payment of the Exercise Price from time to time in its sole discretion. Further, notwithstanding any provision within this Agreement to the contrary, if the Participant is resident or provides services outside
of the United States, the Company may require that the Participant (or in the event of the Participant’s death, the Participant’s legal representative, as the case may be) exercise the Options only by means of a “same day sale”
transaction (either a “sell-all” transaction or a “sell-to-cover” transaction) as it determines in its sole
discretion, or may require the Participant to sell any Shares acquired under the Plan immediately or within a specified period following the Participant’s Separation from Service (in which case, the Participant hereby agrees that the Company
shall have the authority to issue sale instructions in relation to such Shares on the Participant’s behalf). 
 (d) Restrictions on
Exercise. The Participant may not exercise any Option (i) if it is an Incentive Stock Option and the Plan has not been approved by the Stockholders or (ii) if the issuance of Shares upon exercise or the method of payment for those
Shares would constitute a violation of any Applicable Law or Company policy. 
 4. Change in Control. Upon the consummation of a
Change in Control, any Service Option which were unvested immediately prior to such Change in Control shall be deemed vested (such Options which are subject to accelerated vesting being referred to as the “Accelerated Options”). The
Participant hereby agrees that upon a Change in Control, the Accelerated Options shall be deemed to be automatically exercised through a cashless exercise and Participant shall have no further rights under the Accelerated Options other than payment
of the consideration, if any, (less any applicable taxes and withholdings) to be paid to the Participant (whether in the form of cash or stock) in respect of such deemed exercise of the Accelerated Options as of the Change in Control. 

 5. Rights as Stockholder. Until such time as the Options have been exercised pursuant
to Section 3 and Shares have been issued to the Participant, the Participant shall have no rights as a stockholder, including, without limitation, any right to dividends or other distributions or any right to vote, and no
adjustments shall be made for dividends in cash or other property, distributions or other rights in respect of any such shares of Common Stock, except as otherwise specifically provided for in the Plan or this Agreement. 

6. Taxes. 
 (a) The
Participant acknowledges and agrees that, regardless of any action taken by the Company or, if different, the Affiliate that employs the Participant (the “Employer”), the ultimate liability for all income tax, social insurance,
payroll tax, fringe benefits tax, payment on account or other tax-related items related to the Participant’s participation in the Plan and legally applicable or deemed applicable to the Participant even
if technically due by the Company or an Affiliate (“Tax-Related Items”) is and remains the Participant’s responsibility and may exceed the amount, if any, actually withheld by the Company
or the Employer. The Participant further acknowledges that the Company and/or the Employer (i) make no representations or undertakings regarding the treatment of any Tax-Related Items in connection with
any aspect of the Options or the underlying Shares, including, but not limited to, the grant, vesting or exercise of the Options, the subsequent sale of Shares acquired pursuant to such exercise and the receipt of any dividends and (ii) do not
commit to and are under no obligation to structure the terms of the grant or any aspect of the Options to reduce or eliminate the Participant’s liability for Tax-Related Items or achieve any particular
tax result. Further, if the Participant is subject to Tax-Related Items in more than one jurisdiction, the Participant acknowledges that the Company and/or the Employer (or former employer, as applicable) may
be required to withhold or account for Tax-Related Items in more than one jurisdiction. 
 (b) To
the extent that Tax-Related Items are payable, the Participant shall make arrangements satisfactory to the Company for the satisfaction of obligations for the payment of
Tax-Related Items relating to the Options or the Company may mandate the method for satisfying Tax-Related Items, which arrangements include the delivery of cash or cash
equivalents, Shares (including previously owned Shares, net exercise, a broker-assisted sale, or, if permitted by the Committee, other cashless withholding or reduction of the amount of Shares otherwise issuable or delivered pursuant to this Award),
other property, or any other legal consideration the Committee deems appropriate. If the Participant fails to satisfy such Tax-Related Items, the Company may refuse to issue or transfer any Shares otherwise
required to be issued pursuant to this Agreement. If such Tax-Related Items are satisfied through net exercise or the surrender of previously owned Shares, the maximum number of Shares that may be so withheld
(or surrendered) shall be the number of Shares that have an aggregate Fair Market Value on the date of withholding or surrender approximately equal to the aggregate amount of such Tax-Related Items determined
based on the greatest withholding rates for Tax-Related Items that may be used without creating adverse accounting treatment for the Company with respect to the Options, as determined by the Committee. If the
obligation for Tax-Related Items is satisfied through net exercise, for tax 

 
purposes, the Participant is deemed to have been issued the full number of Shares subject to the Options, notwithstanding that a number of Shares are held back solely for the purpose of paying
the Tax-Related Items. The Participant will have no further rights with respect to any Shares that are retained by the Company pursuant to this provision. In the event of over-withholding, the Participant may
receive a refund of any over-withheld amount in cash (with no entitlement to the equivalent in Shares), or if not refunded, the Participant may be able to seek a refund from the local tax authorities. In the event of under-withholding, the
Participant may be required to pay any additional Tax-Related Items directly to the applicable tax authority or to the Company and/or the Employer. 

(c) If the Options granted hereunder constitute Incentive Stock Options and the Participant makes any disposition of Shares delivered upon
exercise of such Options under the circumstances described in Section 421(b) of the Code (relating to certain disqualifying dispositions), the Participant must notify the Company of such disposition within 10 days following such
disposition. 
 (d) The Participant acknowledges that there may be adverse tax consequences upon the receipt, vesting or exercise of this
Award or disposition of the underlying Shares and that Participant has been advised, and hereby is advised, to consult a tax advisor. The Participant represents that the Participant is in no manner relying on the Board, the Committee, the Company or
an Affiliate or any of their respective managers, directors, officers, employees or authorized representatives (including attorneys, accountants, consultants, bankers, lenders, prospective lenders and financial representatives) for tax advice or an
assessment of such tax consequences. 
 7. Non-Transferability. Except as set forth in
Section 6.3(e) of the Plan, the Options may not, at any time prior to being settled, be assigned, alienated, pledged, attached, sold, or otherwise transferred or encumbered by the Participant, other than by will or by the laws of descent and
distribution, and are exercisable during the Participant’s lifetime only by him or her (or his or her legal representative in the event of incapacity). Any such purported assignment, alienation, pledge, attachment, sale, transfer, or
encumbrance shall be void and unenforceable against the Company. 
 8. Miscellaneous. 

(a) Clawback. All awards, amounts, and benefits received or outstanding under the Plan will be subject to clawback, cancellation,
recoupment, rescission, payback, reduction, or other similar action in accordance with the terms of any Company clawback or similar policy or any Applicable Law related to such actions, as may be in effect from time to time. The Participant
acknowledges and expressly agrees to the Company’s application, implementation, and enforcement of any applicable Company clawback or similar policy that may apply to the Participant, whether adopted before or after the Grant Date (including
the forfeiture, clawback, and detrimental conduct terms contained in Section 13.22 of the Plan as of the Grant Date (and any successor terms)), and any term of Applicable Law relating to clawback, cancellation, recoupment, rescission, payback,
or reduction of compensation, and the Company may take such actions as may be necessary to effectuate any such policy or Applicable Law, without further consideration or action. 

 (b) Compliance with Laws. The grant of Options and the issuance of Shares hereunder
shall be subject to, and shall comply with, any applicable requirements of any foreign and U.S. federal and state securities laws, rules, and regulations (including, without limitation, the provisions of the Securities Act, the Exchange Act, and in
each case any respective rules and regulations promulgated thereunder) and any other law, rule, regulation, or exchange requirement applicable thereto. No shares of Common Stock will be issued hereunder if such issuance would constitute a violation
of any applicable law or regulation or the requirements of any stock exchange or market system upon which the Common Stock may then be listed. In addition, shares of Common Stock will not be issued hereunder unless (a) a registration statement
under the Securities Act is in effect at the time of such issuance with respect to the shares to be issued or (b) in the opinion of legal counsel to the Company, the shares to be issued are permitted to be issued in accordance with the terms of
an applicable exemption from the registration requirements of the Securities Act. The inability of the Company to obtain from any regulatory body having jurisdiction the authority, if any, deemed by the Company’s legal counsel to be necessary
for the lawful issuance and sale of any shares of Common Stock hereunder will relieve the Company of any liability in respect of the failure to issue such shares as to which such requisite authority has not been obtained. As a condition to any
issuance of Common Stock hereunder, the Company may require the Participant to satisfy any requirements that may be necessary or appropriate to evidence compliance with any applicable law or regulation and to make any representation or warranty with
respect to such compliance as may be requested by the Company. 
 (c) Not a Public Offering. If the Participant is employed or
resident outside the United States, the grant of the Options is not intended to be a public offering of securities in the Participant’s country of employment (or country of residence, if different). The Company has not submitted any
registration statement, prospectus or other filings with the local securities authorities (unless otherwise required under local law), and the grant of the Options is not subject to the supervision of the local securities authorities. 

(d) Insider Trading; Market Abuse Laws. By participating in the Plan, the Participant agrees to comply with the Company’s
policy on insider trading (to the extent that it is applicable to the Participant). The Participant further acknowledges that, depending on the Participant’s or his or her broker’s country of residence or where the Shares are listed, the
Participant may be subject to insider trading restrictions and/or market abuse laws which may affect the Participant’s ability to accept, acquire, sell or otherwise dispose of Shares, rights to Shares (e.g., Options) or rights linked to the
value of Shares, during such times the Participant is considered to have “inside information” regarding the Company as defined by the laws or regulations in the Participant’s country. Local insider trading laws and regulations may
prohibit the cancellation or amendment of orders the Participant places before he or she possessed inside information. Furthermore, the Participant could be prohibited from (i) disclosing the inside information to any third party (other than on
a “need to know” basis) and (ii) “tipping” third parties or causing them otherwise to buy or sell securities. The Participant understands that third parties include fellow employees. Any restrictions under these laws or
regulations are separate from and in addition to any restrictions that may be imposed under any applicable Company insider trading policy. The Participant acknowledges that it is the Participant’s responsibility to comply with any applicable
restrictions, and that the Participant should therefore consult his or her personal advisor on this matter. 

 (e) Repatriation; Compliance with Law. The Participant agrees to repatriate
all payments attributable to the Shares and/or cash acquired under the Plan in accordance with applicable foreign exchange rules and regulations in the Participant’s country of employment (and country of residence, if different). In addition,
the Participant agrees to take any and all actions, and consents to any and all actions taken by the Company and any of its Affiliates, as may be required to allow the Company and any of its Affiliates to comply with local laws, rules and/or
regulations in the Participant’s country of employment (and country of residence, if different). Finally, the Participant agrees to take any and all actions as may be required to comply with the Participant’s personal obligations under
local laws, rules and/or regulations in his or her country of employment (and country of residence, if different). 
 (f) Successors.
The terms of this Agreement shall be binding upon and inure to the benefit of the Company and its successors and assigns, and of the Participant and the beneficiaries, executors, administrators, and heirs of the Participant. 

(g) No Waiver; Amendment. No waiver of any right hereunder by any party shall operate as a waiver of any other right, or as a waiver of
the same right with respect to any subsequent occasion for its exercise, or as a waiver of any right to damages. No waiver by any party of any breach of this Agreement shall be held to constitute a waiver of any other breach or a waiver of the
continuation of the same breach. This Agreement may be amended at any time by the Committee, except that no amendment may, without the Participant’s consent, materially impair the Participant’s rights under the Award. 

(h) Severability. The invalidity or unenforceability of any provision of this Agreement shall not affect the validity or enforceability
of any other provision of this Agreement, and each other provision of this Agreement shall be severable and enforceable to the extent permitted by law. 

(i) Nature of Grant. In accepting the Options, the Participant acknowledges and agrees that: 

(i) the Plan is established voluntarily by the Company, it is discretionary in nature and it may be modified, amended, suspended or
terminated by the Company, in its sole discretion, at any time (subject to any limitations set forth in the Plan); 
 (ii) the grant of the
Options is exceptional, voluntary and occasional and does not create any contractual or other right to receive future grants of Options, or benefits in lieu of Options, even if Options or other awards have been granted in the past; 

(iii) all decisions with respect to future awards, if any, will be at the sole discretion of the Company; 

(iv) the Participant’s participation in the Plan is voluntary; 

(v) the Options and the Participant’s participation in the Plan shall not create a right to employment or be interpreted as forming an
employment contract with the Company or any of its Affiliates and shall not interfere with the ability of the Company or the Employer, as applicable, to terminate the Participant’s employment relationship (as otherwise may be permitted under
local law); 

 (vi) unless otherwise agreed with the Company, the Options and any Shares acquired upon
exercise of the Options, and the income from and value of the same, are not granted as consideration for, or in connection with, any service the Participant may provide as a director of any Subsidiary or Affiliate; 

(vii) the Options and any Shares acquired under the Plan and the income and value of the same, are not part of normal or expected
compensation for purposes of calculating any severance, resignation, termination, redundancy, dismissal, end-of-service payments, bonuses, long-service awards, holiday
pay, pension or retirement or welfare benefits or similar payments and in no event should be considered as compensation for, or relating in any way to, past services for the Company, the Employer or any of their Affiliates; 

(viii) the future value of the Shares underlying the Options is unknown, indeterminable, and cannot be predicted with certainty; 

(ix) no claim or entitlement to compensation or damages shall arise from forfeiture of the Options resulting from the Participant’s
Separation from Service (for any reason whatsoever and whether or not in breach of local labor laws or later found invalid) and, in consideration of the Options, the Participant agrees not to institute any claim against the Company or the Employer;

 (x) for purposes of the Options, the Participant’s employment will be considered terminated as of the date the Participant is no
longer actively providing service (regardless of the reason for such termination and whether or not later found to be invalid or in breach of employment laws in the jurisdiction where the Participant is providing service or the terms of the
Participant’s employment or service agreement, if any), and unless otherwise determined by the Company, the Participant’s right to vest in the Options and the period (if any) during which the Participant may exercise the Options after such
termination of the Participant’s service will terminate as of such date and will not be extended by any notice period (e.g., the Participant’s period of service would not include any contractual notice period or any period of “garden
leave” or similar period mandated under employment laws in the jurisdiction where Participant is providing service or the terms of Participant’s employment or service agreement, if any); the Committee or its delegate shall have the
exclusive discretion to determine when the Participant is no longer actively providing service for purposes of his or her Award (including whether the Participant may still be considered to be providing service while on a leave of absence); 

(xi) the Options and the benefits evidenced by this Agreement do not create any entitlement not otherwise specifically provided for in the
Plan or provided by the Company in its discretion, to have the Options or any such benefits transferred to, or assumed by, another company, nor to be exchanged, cashed out or substituted for, in connection with any corporate transaction affecting
the Shares; and 

 (xii) if the Participant’s local currency is different than the U.S. dollar, neither
the Company nor any of its Affiliates shall be liable for any foreign exchange rate fluctuation between the Participant’s local currency and the U.S. dollar that may affect the value of the Options or any amounts due to the Participant pursuant
to the exercise of the Options or the subsequent sale of any Shares acquired upon exercise of the Options. 
 (j) Appendix.
Notwithstanding any provisions in this Agreement, the Options shall be subject to any additional or different terms and conditions set forth in the Appendix to this Agreement for certain country or countries (the “Appendix”).
Moreover, if the Participant relocates to any country included in the Appendix, the special terms and conditions for such country will apply to the Participant, to the extent the Company determines that the application of such terms and conditions
is necessary or advisable for legal or administrative reasons or the Company may establish additional terms to facilitate the Participant’s relocation. The Appendix constitutes part of this Agreement. 

(k) Imposition of Other Requirements. The Company reserves the right to impose other requirements on the Participant’s
participation in the Plan, on the Options, and on any Shares acquired under the Plan, to the extent the Company determines it is necessary or advisable for legal or administrative reasons, and to require the Participant to sign any additional
agreements or undertakings that may be necessary to accomplish the foregoing. 
 (l) Entire Agreement. This Agreement (including the
Appendix), the Grant Notice, and the Plan contain the entire agreement and understanding of the parties hereto with respect to the subject matter contained herein and supersede all prior communications, representations, and negotiations with respect
thereto. 
 (m) Bound by the Plan. By signing this Agreement, the Participant acknowledges that the Participant has received a copy
of the Plan and has had an opportunity to review the Plan and agrees to be bound by all the terms and provisions of the Plan. In the event of any conflict between the Plan and this Agreement, this Agreement shall control. 

(n) Governing Law. The Participant acknowledges and expressly agrees to the governing law terms of Section 13.9 of the Plan (and
any successor terms) and the jurisdiction and waiver of jury trial terms of Section 13.10 of the Plan (and any successor terms). 
 (o)
Business Days. If any time period for giving notice or taking action hereunder expires on a day that is a Saturday, Sunday, or holiday in the state in which the Company’s principal executive office is located, the time period shall be
automatically extended to the business day immediately following such Saturday, Sunday, or holiday. 
 (p) Headings. The headings of
the Sections hereof are provided for convenience only and are not to serve as a basis for interpretation or construction, and shall not constitute a part, of this Agreement. 

(q) Counterparts. This Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original, but all
of which taken together shall constitute one and the same instrument. 

 (r) Section 409A of the Code. It is intended that the Options
granted pursuant to this Agreement and the provisions of this Agreement be exempt from Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and all provisions of this Agreement shall be construed and
interpreted in a manner consistent with the requirements for avoiding taxes or penalties under Section 409A of the Code. 
 (s)
Language. If the Participant is resident in a country where English is not an official language, the Participant acknowledges and agrees that it is his or her express intent that this Agreement and the Plan and all other documents,
notices and legal proceedings entered into, given or instituted pursuant to the Options be drawn up in English. Further, the Participant acknowledges that he or she is sufficiently proficient in English to understand the terms and conditions of this
Agreement and any documents related to the Plan or has had the ability to consult with an advisor who is sufficiently proficient in the English language. If the Participant has received this Agreement or any other document related to the Plan
translated into a language other than English and if the meaning of the translated version is different than the English version, the English version will control. 

(t) Data Privacy. The Participant hereby explicitly and unambiguously consents to the collection, use and transfer, in
electronic or other form, of the Participant’s personal data as described in this Agreement, the Grant Notice and any other grant materials by and among, as necessary and applicable, the Company and its Affiliates, for the
exclusive purpose of implementing, administering and managing the Participant’s participation in the Plan. 
 The
Participant understands that the Company, its Affiliates and/or the Employer may hold certain personal information about the Participant, specifically, [the Participant’s name, home address, email address and telephone number, date of birth,
social security or insurance number, passport number or other identification number, salary, nationality, and any Shares or directorships held in the Company, and details of the Options or any other entitlement to Shares, canceled, exercised,
vested, unvested or outstanding in the Participant’s favor] (“Data”), for the purpose of implementing, administering and managing the Plan. 

The Participant understands that Data will be transferred to Fidelity Stock Plan Services or such other stock plan service provider as may
be selected by the Company in the future, which is assisting the Company with the implementation, administration and management of the Plan. The Participant understands that the recipients of Data may be located in the United States or elsewhere,
and that the recipients’ country (e.g., the United States) may have different data privacy laws and protections than the Participant’s country. If the Participant is employed outside the United States, the Participant understands that the
Participant may request a list with the names and addresses of any potential recipients of Data by contacting his or her local human resources representative. The Participant authorizes the Company, the applicable stock plan service provider and any
other possible recipients that may assist the Company (presently or in the future) with implementing, administering and managing the Plan to receive, possess, use, retain and transfer Data, in electronic or other form, for the sole purpose of
implementing, administering and managing the Participant’s participation in the Plan. The Participant understands that Data will be held only as long as is necessary to implement, administer and manage the Participant’s participation in
the Plan. If the Participant is employed outside the United States, the Participant understands that he or she may, at any time, view Data, request 

 
additional information about the storage and processing of Data, require any necessary amendments to Data or refuse or withdraw the consents herein, in any case without cost, by contacting in
writing his or her local human resources representative. Further, the Participant understands that he or she is providing the consents herein on a purely voluntary basis. If the Participant does not consent, or if the Participant later seeks to
revoke the Participant’s consent, his or her service status and career will not be affected; the only consequence of refusing or withdrawing the Participant’s consent is that the Company would not be able to grant the Options or other
equity awards to the Participant or administer or maintain such awards. Therefore, the Participant understands that refusing or withdrawing the Participant’s consent may affect his or her ability to participate in the Plan. For more information
on the consequences of the Participant’s refusal to consent or withdrawal of consent, the Participant understands that the Participant may contact his or her local human resources representative. 

(u) Consent to Electronic Delivery; Electronic Signature. In lieu of receiving documents in paper format, the Participant agrees,
to the fullest extent permitted by law, to accept electronic delivery of any documents that the Company may be required to deliver (including, without limitation, prospectuses, prospectus supplements, grant or award notifications and agreements,
account statements, annual and quarterly reports and all other forms of communications) in connection with this and any other Award made or offered by the Company. Electronic delivery may be via a Company electronic mail system or by reference to a
location on a Company intranet or third party website to which the Participant has access. The Participant hereby consents to any and all procedures the Company has established or may establish for an electronic signature system for delivery and
acceptance of any such documents that the Company may be required to deliver, and agrees that the Participant’s electronic signature is the same as, and shall have the same force and effect as, the Participant’s manual signature. 

*         *        
*         * 

 APPENDIX TO THE AGREEMENT 

COUNTRY-SPECIFIC TERMS, CONDITIONS AND NOTIFICATIONS 

Terms and Conditions 
 This Appendix includes
additional terms and conditions that govern the Options granted to the Participant under the Plan if the Participant resides and/or works outside of the United States. Capitalized terms used but not defined herein shall have the meanings ascribed to
them in the Grant Notice, the Plan and/or the Agreement to which this Appendix is attached. 
 If the Participant is a citizen or resident of a country
other than the one in which the Participant is currently working and/or residing, transfers to another country after the Grant Date, is a consultant, changes employment status to a consultant, or is considered a resident of another country for local
law purposes, the Company shall, in its discretion, determine the extent to which the terms and conditions contained herein shall be applicable to the Participant. References to the Employer shall include any entity that engages the
Participant’s services. 
 Notifications 

This Appendix also includes information regarding securities, tax, and certain other issues of which the Participant should be aware with respect to
participation in the Plan. The information is provided solely for the Participant’s convenience and is based on the securities, tax, and other laws in effect in the respective countries as of June 2021. Such laws are often complex and
change frequently. As a result, the Company strongly recommends that the Participant not rely on the information noted herein as the only source of information relating to the consequences of participation in the Plan because the information may be
out of date by the time the Participant vests in, exercises or receives Shares underlying the Options or sells any Shares. 
 In addition, the information
contained in this Appendix is general in nature and may not apply to the Participant’s particular situation, and the Company is not in a position to assure the Participant of any particular result. Accordingly, the Participant should seek
appropriate professional advice as to how the applicable laws in the Participant’s country may apply to his or her situation. 
 Finally, the
Participant understands that if the Participant is a citizen or resident of a country other than the one in which he or she is currently residing and/or working, transfer to another country after the Grant Date, or is considered a resident of
another country for local law purposes, the notifications contained herein may not be applicable to the Participant in the same manner. 

 SINGAPORE 

Securities Law Information. The grant of the Options under the Plan is being made pursuant to the “Qualifying Person” exemption under section
273(1)(f) of the Securities and Futures Act (Chapter 289, 2006 Ed.) (“SFA”). The Plan has not been and will not be lodged or registered as a prospectus with the Monetary Authority of Singapore and is not regulated by any financial
supervisory authority pursuant to any legislation in Singapore. Accordingly, statutory liability under the SFA in relation to the content of prospectuses would not apply. The Participant should note that the Options are subject to section 257 of the
SFA and the Participant will not be able to make any subsequent sale of the underlying Shares in Singapore, or any offer of such subsequent sale of the Shares subject to the Options in Singapore, unless such sale or offer is made (i) after
six (6) months from the date of grant or (ii) pursuant to the exemptions under Part XIII Division (1) Subdivision (4) (other than section 280) of the SFA. 

UNITED KINGDOM 
 1. Taxes. This
provision shall supplement Section 5 of the Agreement: 
 Without limitation to Section 5 of the Agreement, the Participant
agrees that he or she is liable for all Tax-Related Items and hereby covenants to pay all such Tax-Related Items, as and when requested by the Company, the Employer or
by Her Majesty’s Revenue and Customs (“HMRC”) (or any other tax authority or any other relevant authority). The Participant also agrees to indemnify and keep indemnified the Company and the Employer against any Tax-Related Items that they are required to pay or withhold or have paid or will pay on the Participant’s behalf to HMRC (or any other tax authority or any other relevant authority). 

Notwithstanding the foregoing, if the Participant is a director or executive officer (as within the meaning of Section 13(k) of the Exchange Act), the
terms of the immediately foregoing provision will not apply. In the event that the Participant is a director or executive officer and income tax due is not collected from or paid by the Participant by within 90 days after the U.K. tax year in which
an event giving rise to the indemnification described above occurs, the amount of any uncollected tax may constitute a benefit to the Participant on which additional income tax and national insurance contributions may be payable. The Participant
acknowledges that the Participant ultimately will be responsible for reporting and paying any income tax due on this additional benefit directly to HMRC under the self-assessment regime and for reimbursing the Company or the Employer (as applicable)
for the value of any employee national insurance contributions due on this additional benefit, which the Company and/or the Employer may recover from the Participant at any time thereafter by any of the means referred to in Section 5 of the
Agreement. 
 2. Exclusion of Claim. The Participant acknowledges and agrees that the Participant will have no entitlement to compensation or
damages insofar as such entitlement arises or may arise from the Participant ceasing to have rights under or to be entitled to the Options, whether or not as a result of a Separation from Service (whether the termination is in breach of contract or
otherwise), or from the loss or diminution in value of the Options. Upon the grant of the Options, the Participant will be deemed to have waived irrevocably any such entitlement. 

 3. Data Privacy Notice. If the Participant resides and/or works in the United Kingdom, the
following provision replaces Section 8(t) of the Agreement: 
 The Company, with its principal office at 95 Morton St., 8th Floor,
New York, New York 10014, United States of America, is the controller responsible for the processing of the Participant’s personal data by the Company and the third parties noted below. 

(a) Data Collection, Processing and Usage. Pursuant to applicable data protection laws, the Participant is hereby notified that the
Company collects, processes and uses certain personal information about the Participant for the legitimate purpose of implementing, administering and managing the Plan and generally administering Options, specifically [the Participant’s name,
home address, email address and telephone number, date of birth, social security or insurance number, passport number or other identification number, salary, nationality, and any Shares or directorships held in the Company, and details of the
Options or any other entitlement to Shares, canceled, exercised, vested, unvested or outstanding in the Participant’s favor] (“Personal Data”). In granting Options under the Plan, the Company will collect, process, use,
disclose and transfer (collectively, “Processing”) Personal Data for purposes of implementing, administering and managing the Plan. The Company’s legal basis for the Processing of Personal Data is the Company’s legitimate
business interests of managing the Plan, administering Options and complying with its contractual and statutory obligations, as well as the necessity of the Processing for the Company to perform its contractual obligations under this Agreement and
the Plan. The Participant’s refusal to provide Personal Data would make it impossible for the Company to perform its contractual obligations and may affect the Participant’s ability to participate in the Plan. As such, by accepting the
Options, the Participant voluntarily acknowledges the Processing of his or her Personal Data as described herein. 
 (b) Outside Service
Providers. The Company and the Employer may transfer Personal Data to Fidelity Stock Plan Services, LLC and its affiliates, an independent service provider based in the United States of America (the “Plan Broker”), which assists
the Company with the implementation, administration and management of the Plan. In the future, the Company may select a different service provider and share the Participant’s Personal Data with another company that serves in a similar manner.
The Processing of Personal Data will take place through both electronic and non-electronic means. Personal Data will only be accessible by those individuals requiring access to it for purposes of implementing,
administering and operating the Plan. When receiving the Participant’s Personal Data, if applicable, the Plan Broker provides appropriate safeguards in accordance with the Standard Contractual Clauses or other appropriate cross-border transfer
solutions. By accepting the Options, the Participant understands that the Plan Broker will Process the Participant’s Personal Data for the purposes of implementing, administering and managing the Participant’s participation in the Plan.

 (c) International Personal Data Transfers. The Plan and Options are administered in the United States of America, which means it
will be necessary for Personal Data to be transferred to, and Processed in the United States of America. When transferring Personal Data to the United States of America, the Company provides appropriate safeguards in accordance with the Standard
Contractual Clauses or other appropriate cross-border transfer solutions. The Participant may request a copy of the appropriate safeguards with the Plan Broker or the Company by contacting [the Participant’s human resources representative].

 (d) Data Retention. The Company will use the Participant’s personal data only as
long as is necessary to implement, administer and manage his or her participation in the Plan or as required to comply with legal or regulatory obligations, including under tax, exchange control, securities, and labor laws. When the Company no
longer needs Personal Data related to the Plan, the Company will remove it from its systems. If the Company keeps Personal Data longer, it would be to satisfy legal or regulatory obligations and the Company’s legal basis would be for compliance
with Applicable Law. 
 (e) Data Subject Rights. To the extent provided by law, the Participant has the right to (i) subject to
certain exceptions, request access or copies of Personal Data the Company Processes, (ii) request rectification of incorrect Personal Data, (iii) request deletion of Personal Data, (iv) place restrictions on Processing of Personal
Data, (v) lodge complaints with competent authorities in the Participant’s country, and/or (vi) request a list with the names and addresses of any potential recipients of Personal Data. To receive clarification regarding the
Participant’s rights or to exercise the Participant’s rights, the Participant may contact [the Participant’s human resources representative]. The Participant also has the right to object, on grounds related to a particular situation,
to the Processing of Personal Data, as well as opt-out of the Plan, in any case without cost, by contacting [the Participant’s human resources representative] in writing. The Participant’s provision
of Personal Data is a contractual requirement. The Participant understands, however, that the only consequence of refusing to provide Personal Data is that the Company may not be able to administer the Options, or grant other awards or administer or
maintain such awards. For more information on the consequences of the refusal to provide Personal Data, the Participant may contact [the Participant’s human resources representative] in writing. 

*         *         *
        *

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00329-of-00352.parquet"}]]